$JXN
Jackson Financial Inc. Stock $jxn

$jxn Overview Financials Valuation SEC Filings Company Website

2024 Q2 Form 10-Q Financial Statement

#000182299324000020 Filed on May 08, 2024

Income Statement

Concept	2024 Q2	2024 Q1	2023 Q1
Revenue	$1.247B	-$322.0M	$9.863B
YoY Change	-43.85%	-103.26%	129.32%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$1.119B	$1.106B	$1.022B
YoY Change	7.39%	8.22%	3.02%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization			$1.226B
YoY Change			40766.67%
% of Gross Profit
Operating Expenses	$903.0M	-$1.250B	$1.262B
YoY Change	-181.13%	-199.05%	-33.4%
Operating Profit
YoY Change
Interest Expense	$26.00M	$25.00M	$43.00M
YoY Change	-55.17%	-41.86%	115.0%
% of Operating Profit
Other Income/Expense, Net			-$36.00M
YoY Change			-250.0%
Pretax Income	$318.0M	$903.0M	$7.734B
YoY Change	-87.83%	-88.32%	224.14%
Income Tax	$36.00M	$101.0M	$1.505B
% Of Pretax Income	11.32%	11.18%	19.46%
Net Earnings	$275.0M	$795.0M	$6.186B
YoY Change	-87.47%	-87.15%	205.48%
Net Earnings / Revenue	22.05%		62.72%
Basic Earnings Per Share	$3.45	$10.04	$72.34
Diluted Earnings Per Share	$3.43	$9.94	$69.75
COMMON SHARES
Basic Shares Outstanding	76.26M shares	77.41M shares	82.28M shares
Diluted Shares Outstanding	77.08M shares	78.87M shares	82.65M shares

Balance Sheet

Concept	2024 Q2	2024 Q1	2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents	$1.736B	$2.542B	$1.779B
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$69.12B	$68.11B	$65.83B
YoY Change	9.13%	3.46%	-3.78%
Other Assets	$768.0M	$749.0M	$755.0M
YoY Change	12.78%	-0.79%	-43.78%
Total Long-Term Assets
YoY Change
TOTAL ASSETS
Total Short-Term Assets
Total Long-Term Assets
Total Assets	$337.8B	$340.3B	$315.0B
YoY Change	3.3%	8.03%	-10.68%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$116.0M	$92.00M	$545.0M
YoY Change	-76.71%	-83.12%	3.81%
LONG-TERM LIABILITIES
Long-Term Debt	$2.034B	$2.033B	$2.632B
YoY Change	-22.75%	-22.76%	-0.3%
Other Long-Term Liabilities	$9.899B	$9.480B	$6.053B
YoY Change	67.33%	56.62%	26.61%
Total Long-Term Liabilities	$11.93B	$11.51B	$8.685B
YoY Change	39.58%	32.56%	17.03%
TOTAL LIABILITIES
Total Short-Term Liabilities	$116.0M	$92.00M	$545.0M
Total Long-Term Liabilities	$11.93B	$11.51B	$8.685B
Total Liabilities	$327.5B	$329.9B	$305.6B
YoY Change	3.13%	7.96%	-10.73%
SHAREHOLDERS EQUITY
Retained Earnings	$7.965B	$7.766B	$6.403B
YoY Change	33.82%	21.29%	33.9%
Common Stock	$1.000M	$1.000M	$1.000M
YoY Change	0.0%	0.0%	0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)			$510.0M
YoY Change			45.3%
Treasury Stock Shares			13.43M shares
Shareholders Equity	$10.08B	$10.17B	$8.638B
YoY Change
Total Liabilities & Shareholders Equity	$337.8B	$340.3B	$315.0B
YoY Change	3.3%	8.03%	-10.68%

Cashflow Statement

Concept	2024 Q2	2024 Q1	2023 Q1
OPERATING ACTIVITIES
Net Income	$275.0M	$795.0M	$6.186B
YoY Change	-87.47%	-87.15%	205.48%
Depreciation, Depletion And Amortization			$1.226B
YoY Change			40766.67%
Cash From Operating Activities	$1.478B	$1.426B	$5.206B
YoY Change	36.1%	-72.61%	505.35%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities	-$1.914B	$73.00M	-$282.0M
YoY Change	-2553.85%	-125.89%	-1009.68%
Cash From Investing Activities	-$1.914B	-$2.006B	-$2.882B
YoY Change	-2553.85%	-30.4%	1326.73%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net		$345.0M	$0.00
YoY Change
Cash From Financing Activities	-369.0M	$433.0M	-$1.099B
YoY Change	-56.18%	-139.4%	80.46%
NET CHANGE
Cash From Operating Activities	1.478B	$1.426B	$5.206B
Cash From Investing Activities	-1.914B	-$2.006B	-$2.882B
Cash From Financing Activities	-369.0M	$433.0M	-$1.099B
Net Change In Cash	-805.0M	-$147.0M	-$2.520B
YoY Change	-350.0%	-94.17%	-5242.86%
FREE CASH FLOW
Cash From Operating Activities	$1.478B	$1.426B	$5.206B
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2024Q1	us-gaap	Premiums Earned Net PremiumsEarnedNet	38000000	usd
CY2024Q1	jxn	Net Investment Income Excluding Funds Withheld Assets NetInvestmentIncomeExcludingFundsWithheldAssets	464000000	usd
CY2023Q1	jxn	Net Investment Income Excluding Funds Withheld Assets NetInvestmentIncomeExcludingFundsWithheldAssets	400000000	usd
CY2023Q1	jxn	Net Investment Income Funds Withheld Assets NetInvestmentIncomeFundsWithheldAssets	307000000	usd
CY2024Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	22000	shares
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	22000	shares
CY2024Q1	us-gaap	Preferred Stock Value PreferredStockValue	533000000	usd
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	1000000000	shares
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2024Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	76621374	shares
CY2024Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	76621374	shares
CY2024Q1	us-gaap	Common Stock Value CommonStockValue	1000000	usd
CY2024Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	6005000000	usd
CY2024Q1	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	17859632	shares
CY2024Q1	us-gaap	Treasury Stock Common Value TreasuryStockCommonValue	713000000	usd
CY2024Q1	us-gaap	Aoci Tax Attributable To Parent AociTaxAttributableToParent	-274000000	usd
CY2024Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-3423000000	usd
CY2024Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	7766000000	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	10169000000	usd
CY2024Q1	us-gaap	Minority Interest MinorityInterest	187000000	usd
CY2024Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	10356000000	usd
CY2024Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	340280000000	usd
CY2024Q1	us-gaap	Fee Income FeeIncome	1998000000	usd
CY2023Q1	us-gaap	Premiums Earned Net PremiumsEarnedNet	25000000	usd
CY2024Q1	jxn	Net Investment Income Funds Withheld Assets NetInvestmentIncomeFundsWithheldAssets	270000000	usd
CY2024Q1	us-gaap	Net Investment Income NetInvestmentIncome	734000000	usd
CY2023Q1	us-gaap	Net Investment Income NetInvestmentIncome	707000000	usd
CY2024Q1	jxn	Gain Loss On Investments And Derivative Instruments GainLossOnInvestmentsAndDerivativeInstruments	-2892000000	usd
CY2023Q1	jxn	Gain Loss On Investments And Derivative Instruments GainLossOnInvestmentsAndDerivativeInstruments	-2726000000	usd
CY2024Q1	jxn	Gain Loss On Funds Withheld Reinsurance Treaties GainLossOnFundsWithheldReinsuranceTreaties	-201000000	usd
CY2023Q1	jxn	Gain Loss On Funds Withheld Reinsurance Treaties GainLossOnFundsWithheldReinsuranceTreaties	-673000000	usd
CY2024Q1	jxn	Gain Loss On Investments And Derivative Instruments Net GainLossOnInvestmentsAndDerivativeInstrumentsNet	-3093000000	usd
CY2023Q1	jxn	Gain Loss On Investments And Derivative Instruments Net GainLossOnInvestmentsAndDerivativeInstrumentsNet	-3399000000	usd
CY2024Q1	us-gaap	Other Income OtherIncome	1000000	usd
CY2023Q1	us-gaap	Other Income OtherIncome	15000000	usd
CY2024Q1	us-gaap	Revenues Revenues	-322000000	usd
CY2023Q1	us-gaap	Revenues Revenues	-764000000	usd
CY2024Q1	jxn	Death Other Policy Benefits And Change In Policy Reserves Net Of Deferrals DeathOtherPolicyBenefitsAndChangeInPolicyReservesNetOfDeferrals	221000000	usd
CY2023Q1	jxn	Death Other Policy Benefits And Change In Policy Reserves Net Of Deferrals DeathOtherPolicyBenefitsAndChangeInPolicyReservesNetOfDeferrals	228000000	usd
CY2024Q1	us-gaap	Liability For Future Policy Benefit Remeasurement Gain Loss LiabilityForFuturePolicyBenefitRemeasurementGainLoss	-11000000	usd
CY2023Q1	us-gaap	Liability For Future Policy Benefit Remeasurement Gain Loss LiabilityForFuturePolicyBenefitRemeasurementGainLoss	-14000000	usd
CY2024Q1	us-gaap	Market Risk Benefit Change In Fair Value Gain Loss MarketRiskBenefitChangeInFairValueGainLoss	2718000000	usd
CY2023Q1	us-gaap	Market Risk Benefit Change In Fair Value Gain Loss MarketRiskBenefitChangeInFairValueGainLoss	174000000	usd
CY2024Q1	us-gaap	Interest Credited To Policyholders Account Balances InterestCreditedToPolicyholdersAccountBalances	273000000	usd
CY2023Q1	us-gaap	Interest Credited To Policyholders Account Balances InterestCreditedToPolicyholdersAccountBalances	285000000	usd
CY2024Q1	us-gaap	Interest Expense InterestExpense	25000000	usd
CY2023Q1	us-gaap	Interest Expense InterestExpense	28000000	usd
CY2024Q1	us-gaap	Costs And Expenses CostsAndExpenses	685000000	usd
CY2023Q1	us-gaap	Costs And Expenses CostsAndExpenses	616000000	usd
CY2024Q1	jxn	Expense Income From Amortization Of Deferred Acquisition Costs ExpenseIncomeFromAmortizationOfDeferredAcquisitionCosts	278000000	usd
CY2023Q1	jxn	Expense Income From Amortization Of Deferred Acquisition Costs ExpenseIncomeFromAmortizationOfDeferredAcquisitionCosts	293000000	usd
CY2024Q1	us-gaap	Benefits Losses And Expenses BenefitsLossesAndExpenses	-1225000000	usd
CY2023Q1	us-gaap	Benefits Losses And Expenses BenefitsLossesAndExpenses	1290000000	usd
CY2024Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	903000000	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2054000000	usd
CY2024Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	101000000	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-558000000	usd
CY2024Q1	us-gaap	Profit Loss ProfitLoss	802000000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-1496000000	usd
CY2024Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	7000000	usd
CY2023Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	1000000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	795000000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-1497000000	usd
CY2024Q1	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	11000000	usd
CY2023Q1	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	0	usd
CY2024Q1	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	784000000	usd
CY2024Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	784000000	usd
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-1497000000	usd
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-1497000000	usd
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	10.04
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-18.11
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	9.94
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-18.11
CY2024Q1	us-gaap	Profit Loss ProfitLoss	802000000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-1496000000	usd
CY2024Q1	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax	-3000000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax	92000000	usd
CY2024Q1	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-278000000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	968000000	usd
CY2024Q1	jxn	Oci Debt Securities Available For Sale Impaired Unrealized Holding Gain Loss After Adjustment Tax OCIDebtSecuritiesAvailableForSaleImpairedUnrealizedHoldingGainLossAfterAdjustmentTax	0	usd
CY2023Q1	jxn	Oci Debt Securities Available For Sale Impaired Unrealized Holding Gain Loss After Adjustment Tax OCIDebtSecuritiesAvailableForSaleImpairedUnrealizedHoldingGainLossAfterAdjustmentTax	-2000000	usd
CY2024Q1	jxn	Oci Debt Securities Available For Sale Impaired Unrealized Holding Gain Loss After Adjustment And Tax OCIDebtSecuritiesAvailableForSaleImpairedUnrealizedHoldingGainLossAfterAdjustmentAndTax	0	usd
CY2023Q1	jxn	Oci Debt Securities Available For Sale Impaired Unrealized Holding Gain Loss After Adjustment And Tax OCIDebtSecuritiesAvailableForSaleImpairedUnrealizedHoldingGainLossAfterAdjustmentAndTax	-8000000	usd
CY2024Q1	us-gaap	Oci Liability For Future Policy Benefit Gain Loss After Reclassification Adjustment Tax OciLiabilityForFuturePolicyBenefitGainLossAfterReclassificationAdjustmentTax	18000000	usd
CY2023Q1	us-gaap	Oci Liability For Future Policy Benefit Gain Loss After Reclassification Adjustment Tax OciLiabilityForFuturePolicyBenefitGainLossAfterReclassificationAdjustmentTax	-32000000	usd
CY2024Q1	us-gaap	Oci Liability For Future Policy Benefit Gain Loss After Reclassification Adjustment And Tax OciLiabilityForFuturePolicyBenefitGainLossAfterReclassificationAdjustmentAndTax	63000000	usd
CY2023Q1	us-gaap	Oci Liability For Future Policy Benefit Gain Loss After Reclassification Adjustment And Tax OciLiabilityForFuturePolicyBenefitGainLossAfterReclassificationAdjustmentAndTax	-114000000	usd
CY2024Q1	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax	-111000000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax	60000000	usd
CY2024Q1	us-gaap	Oci Market Risk Benefit Instrument Specific Credit Risk Gain Loss After Adjustments Tax OciMarketRiskBenefitInstrumentSpecificCreditRiskGainLossAfterAdjustmentsTax	400000000	usd
CY2023Q1	us-gaap	Oci Market Risk Benefit Instrument Specific Credit Risk Gain Loss After Adjustments Tax OciMarketRiskBenefitInstrumentSpecificCreditRiskGainLossAfterAdjustmentsTax	-224000000	usd
CY2024Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-615000000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	1070000000	usd
CY2024Q1	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	187000000	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-426000000	usd
CY2024Q1	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	7000000	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	1000000	usd
CY2024Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	180000000	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-427000000	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	10334000000	usd
CY2024Q1	us-gaap	Profit Loss ProfitLoss	802000000	usd
CY2024Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-615000000	usd
CY2024Q1	us-gaap	Minority Interest Period Increase Decrease MinorityInterestPeriodIncreaseDecrease	16000000	usd
CY2024Q1	us-gaap	Dividends Preferred Stock DividendsPreferredStock	11000000	usd
CY2024Q1	us-gaap	Dividends Common Stock DividendsCommonStock	56000000	usd
CY2024Q1	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	120000000	usd
CY2024Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	6000000	usd
CY2024Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	10356000000	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	9378000000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-1496000000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	1070000000	usd
CY2023Q1	us-gaap	Minority Interest Period Increase Decrease MinorityInterestPeriodIncreaseDecrease	96000000	usd
CY2023Q1	us-gaap	Dividends Common Stock DividendsCommonStock	54000000	usd
CY2023Q1	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	70000000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	533000000	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	10000000	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	9467000000	usd
CY2024Q1	us-gaap	Profit Loss ProfitLoss	802000000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-1496000000	usd
CY2024Q1	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	-7000000	usd
CY2023Q1	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	-68000000	usd
CY2024Q1	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-2885000000	usd
CY2023Q1	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-2658000000	usd
CY2024Q1	jxn	Net Gains Losses On Funds Withheld Payable Under Reinsurance Treaties NetGainsLossesOnFundsWithheldPayableUnderReinsuranceTreaties	-201000000	usd
CY2023Q1	jxn	Net Gains Losses On Funds Withheld Payable Under Reinsurance Treaties NetGainsLossesOnFundsWithheldPayableUnderReinsuranceTreaties	-673000000	usd
CY2024Q1	us-gaap	Market Risk Benefit Change In Fair Value Gain Loss MarketRiskBenefitChangeInFairValueGainLoss	2718000000	usd
CY2023Q1	us-gaap	Market Risk Benefit Change In Fair Value Gain Loss MarketRiskBenefitChangeInFairValueGainLoss	174000000	usd
CY2024Q1	us-gaap	Liability For Future Policy Benefit Remeasurement Gain Loss LiabilityForFuturePolicyBenefitRemeasurementGainLoss	-11000000	usd
CY2023Q1	us-gaap	Liability For Future Policy Benefit Remeasurement Gain Loss LiabilityForFuturePolicyBenefitRemeasurementGainLoss	-14000000	usd
CY2024Q1	us-gaap	Interest Credited To Policy Owner Account InterestCreditedToPolicyOwnerAccount	273000000	usd
CY2023Q1	us-gaap	Interest Credited To Policy Owner Account InterestCreditedToPolicyOwnerAccount	285000000	usd
CY2024Q1	jxn	Mortality Expense And Surrender Charges MortalityExpenseAndSurrenderCharges	133000000	usd
CY2023Q1	jxn	Mortality Expense And Surrender Charges MortalityExpenseAndSurrenderCharges	132000000	usd
CY2024Q1	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	14000000	usd
CY2023Q1	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	6000000	usd
CY2024Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-13000000	usd
CY2023Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-553000000	usd
CY2024Q1	us-gaap	Share Based Compensation ShareBasedCompensation	45000000	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	24000000	usd
CY2024Q1	us-gaap	Increase Decrease In Accrued Investment Income Receivable IncreaseDecreaseInAccruedInvestmentIncomeReceivable	-24000000	usd
CY2023Q1	us-gaap	Increase Decrease In Accrued Investment Income Receivable IncreaseDecreaseInAccruedInvestmentIncomeReceivable	-17000000	usd
CY2024Q1	us-gaap	Increase Decrease In Deferred Policy Acquisition Costs IncreaseDecreaseInDeferredPolicyAcquisitionCosts	-128000000	usd
CY2023Q1	us-gaap	Increase Decrease In Deferred Policy Acquisition Costs IncreaseDecreaseInDeferredPolicyAcquisitionCosts	-163000000	usd
CY2024Q1	us-gaap	Increase Decrease In Funds Held Under Reinsurance Agreements IncreaseDecreaseInFundsHeldUnderReinsuranceAgreements	-136000000	usd
CY2023Q1	us-gaap	Increase Decrease In Funds Held Under Reinsurance Agreements IncreaseDecreaseInFundsHeldUnderReinsuranceAgreements	-75000000	usd
CY2024Q1	jxn	Increase Decrease In Future Policy Benefits IncreaseDecreaseInFuturePolicyBenefits	238000000	usd
CY2023Q1	jxn	Increase Decrease In Future Policy Benefits IncreaseDecreaseInFuturePolicyBenefits	122000000	usd
CY2024Q1	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	-30000000	usd
CY2023Q1	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	33000000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	1426000000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	1461000000	usd
CY2024Q1	jxn	Proceeds From Sale And Maturity Of Debt Securities ProceedsFromSaleAndMaturityOfDebtSecurities	2553000000	usd
CY2023Q1	jxn	Proceeds From Sale And Maturity Of Debt Securities ProceedsFromSaleAndMaturityOfDebtSecurities	2931000000	usd
CY2024Q1	us-gaap	Proceeds From Sale Of Equity Securities Fv Ni ProceedsFromSaleOfEquitySecuritiesFvNi	185000000	usd
CY2023Q1	us-gaap	Proceeds From Sale Of Equity Securities Fv Ni ProceedsFromSaleOfEquitySecuritiesFvNi	157000000	usd
CY2024Q1	us-gaap	Proceeds From Sale And Collection Of Finance Receivables ProceedsFromSaleAndCollectionOfFinanceReceivables	360000000	usd
CY2023Q1	us-gaap	Proceeds From Sale And Collection Of Finance Receivables ProceedsFromSaleAndCollectionOfFinanceReceivables	469000000	usd
CY2024Q1	jxn	Payments To Acquire Debt Securities PaymentsToAcquireDebtSecurities	2613000000	usd
CY2023Q1	jxn	Payments To Acquire Debt Securities PaymentsToAcquireDebtSecurities	3325000000	usd
CY2024Q1	us-gaap	Payments To Acquire Equity Securities Fv Ni PaymentsToAcquireEquitySecuritiesFvNi	5000000	usd
CY2023Q1	us-gaap	Payments To Acquire Equity Securities Fv Ni PaymentsToAcquireEquitySecuritiesFvNi	2000000	usd
CY2024Q1	us-gaap	Payments To Acquire Finance Receivables PaymentsToAcquireFinanceReceivables	152000000	usd
CY2023Q1	us-gaap	Payments To Acquire Finance Receivables PaymentsToAcquireFinanceReceivables	348000000	usd
CY2024Q1	jxn	Payments For Proceeds From Derivative Instruments And Collateral On Investments PaymentsForProceedsFromDerivativeInstrumentsAndCollateralOnInvestments	2261000000	usd
CY2023Q1	jxn	Payments For Proceeds From Derivative Instruments And Collateral On Investments PaymentsForProceedsFromDerivativeInstrumentsAndCollateralOnInvestments	3046000000	usd
CY2024Q1	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	73000000	usd
CY2023Q1	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	-282000000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-2006000000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-2882000000	usd
CY2024Q1	us-gaap	Additions To Contract Holders Funds AdditionsToContractHoldersFunds	3860000000	usd
CY2023Q1	us-gaap	Additions To Contract Holders Funds AdditionsToContractHoldersFunds	3874000000	usd
CY2024Q1	us-gaap	Withdrawal From Contract Holders Funds WithdrawalFromContractHoldersFunds	8984000000	usd
CY2023Q1	us-gaap	Withdrawal From Contract Holders Funds WithdrawalFromContractHoldersFunds	7517000000	usd
CY2024Q1	jxn	Transfers To From Separate Accounts TransfersToFromSeparateAccounts	4143000000	usd
CY2023Q1	jxn	Transfers To From Separate Accounts TransfersToFromSeparateAccounts	2060000000	usd
CY2024Q1	us-gaap	Proceeds From Payments For In Securities Sold Under Agreements To Repurchase ProceedsFromPaymentsForInSecuritiesSoldUnderAgreementsToRepurchase	1798000000	usd
CY2023Q1	us-gaap	Proceeds From Payments For In Securities Sold Under Agreements To Repurchase ProceedsFromPaymentsForInSecuritiesSoldUnderAgreementsToRepurchase	76000000	usd
CY2024Q1	jxn	Payments Of Proceeds From Fhl Bank Borrowings Financing Activities PaymentsOfProceedsFromFHLBankBorrowingsFinancingActivities	250000000	usd
CY2023Q1	jxn	Payments Of Proceeds From Fhl Bank Borrowings Financing Activities PaymentsOfProceedsFromFHLBankBorrowingsFinancingActivities	0	usd
CY2024Q1	us-gaap	Repayments Of Other Debt RepaymentsOfOtherDebt	4000000	usd
CY2023Q1	us-gaap	Repayments Of Other Debt RepaymentsOfOtherDebt	4000000	usd
CY2024Q1	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	383000000	usd
CY2023Q1	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	0	usd
CY2024Q1	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	345000000	usd
CY2023Q1	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	0	usd
CY2024Q1	us-gaap	Proceeds From Contributions From Affiliates ProceedsFromContributionsFromAffiliates	17000000	usd
CY2023Q1	us-gaap	Proceeds From Contributions From Affiliates ProceedsFromContributionsFromAffiliates	0	usd
CY2024Q1	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	54000000	usd
CY2023Q1	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	51000000	usd
CY2024Q1	us-gaap	Payments Of Dividends Preferred Stock And Preference Stock PaymentsOfDividendsPreferredStockAndPreferenceStock	11000000	usd
CY2023Q1	us-gaap	Payments Of Dividends Preferred Stock And Preference Stock PaymentsOfDividendsPreferredStockAndPreferenceStock	0	usd
CY2024Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	120000000	usd
CY2023Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	70000000	usd
CY2024Q1	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock	0	usd
CY2023Q1	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock	533000000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	433000000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-1099000000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-147000000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-2520000000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2691000000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	4301000000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2544000000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1781000000	usd
CY2024Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	usd
CY2023Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	usd
CY2024Q1	us-gaap	Interest Paid Net InterestPaidNet	33000000	usd
CY2023Q1	us-gaap	Interest Paid Net InterestPaidNet	21000000	usd
CY2024Q1	jxn	Debt Securities Acquired From Noncash Transactions DebtSecuritiesAcquiredFromNoncashTransactions	27000000	usd
CY2023Q1	jxn	Debt Securities Acquired From Noncash Transactions DebtSecuritiesAcquiredFromNoncashTransactions	32000000	usd
CY2024Q1	jxn	Other Invested Assets Acquired From Stock Splits And Stock Distributions OtherInvestedAssetsAcquiredFromStockSplitsAndStockDistributions	19000000	usd
CY2023Q1	jxn	Other Invested Assets Acquired From Stock Splits And Stock Distributions OtherInvestedAssetsAcquiredFromStockSplitsAndStockDistributions	9000000	usd
CY2024Q1	jxn	Non Cash Dividend Equivalents On Stock Based Awards NonCashDividendEquivalentsOnStockBasedAwards	2000000	usd
CY2023Q1	jxn	Non Cash Dividend Equivalents On Stock Based Awards NonCashDividendEquivalentsOnStockBasedAwards	3000000	usd
CY2024Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2542000000	usd
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1779000000	usd
CY2024Q1	us-gaap	Restricted Cash RestrictedCash	2000000	usd
CY2023Q1	us-gaap	Restricted Cash RestrictedCash	2000000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2544000000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1781000000	usd
CY2024Q1	us-gaap	Use Of Estimates UseOfEstimates	<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of these Condensed Consolidated Financial Statements in conformity with U.S. GAAP requires the use of estimates and assumptions about future events that affect the amounts reported in the Condensed Consolidated Financial Statements and the accompanying notes. Significant estimates or assumptions, as further discussed in these notes, include:</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Valuation of investments and derivative instruments, including fair values of securities deemed to be in an illiquid market and the determination of when an impairment is necessary;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Assessments as to whether certain entities are VIEs, the existence of reconsideration events and the determination of which party, if any, should consolidate the entity;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Assumptions used in calculating policy reserves and liabilities including policyholder behavior, mortality rates, expenses, investment returns and policy crediting rates;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Assumptions as to future earnings levels being sufficient to realize deferred tax benefits;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Estimates related to expectations of credit losses on certain financial assets and off-balance sheet exposures;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Assumptions and estimates associated with the Company’s tax positions, including an estimate of the dividends received deduction, which impact the amount of recognized tax benefits recorded by the Company;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Assumptions used in calculating market risk benefits including policyholder behavior, mortality rates, and capital market assumptions; and</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Assumptions impacting the expected term used in amortizing deferred acquisition costs, including policyholder behavior and mortality rates.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These estimates and assumptions are based on management’s best estimates and judgments. Management evaluates its estimates and assumptions on an ongoing basis using historical experience and other appropriate factors. As facts and circumstances dictate, these estimates and assumptions may be adjusted. Since future events and their effects cannot be determined with precision, actual results could differ significantly from these estimates. Changes in estimates, including those resulting from continuing changes in the economic environment, will be reflected in the Consolidated Financial Statements in the periods the estimates are changed.</span></div>
CY2024Q1	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	896000000	usd
CY2023Q1	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	-2055000000	usd
CY2024Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	101000000	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-558000000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	795000000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-1497000000	usd
CY2024Q1	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	3	segment
CY2024Q1	us-gaap	Revenues Revenues	-322000000	usd
CY2023Q1	us-gaap	Revenues Revenues	-764000000	usd
CY2024Q1	us-gaap	Benefits Losses And Expenses BenefitsLossesAndExpenses	-1225000000	usd
CY2023Q1	us-gaap	Benefits Losses And Expenses BenefitsLossesAndExpenses	1290000000	usd
CY2024Q1	us-gaap	Dividends Preferred Stock DividendsPreferredStock	11000000	usd
CY2023Q1	us-gaap	Dividends Preferred Stock DividendsPreferredStock	0	usd
CY2024Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	784000000	usd
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-1497000000	usd
CY2024Q1	jxn	Debt Securities Rated DebtSecuritiesRated	389000000	usd
CY2023Q4	jxn	Debt Securities Rated DebtSecuritiesRated	486000000	usd
CY2024Q1	jxn	Debt Securities Percentage DebtSecuritiesPercentage	1.000
CY2023Q4	jxn	Debt Securities Percentage DebtSecuritiesPercentage	1.000
CY2024Q1	jxn	Debt Securities Amortized Cost DebtSecuritiesAmortizedCost	47122000000	usd
CY2024Q1	jxn	Debt Securities Allowance For Credit Loss DebtSecuritiesAllowanceForCreditLoss	20000000	usd
CY2024Q1	jxn	Debt Securities Accumulated Gross Unrealized Gain Before Tax DebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	188000000	usd
CY2024Q1	jxn	Debt Securities Accumulated Gross Unrealized Loss Before Tax DebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	4874000000	usd
CY2024Q1	us-gaap	Debt Securities DebtSecurities	42416000000	usd
CY2023Q4	jxn	Debt Securities Amortized Cost DebtSecuritiesAmortizedCost	47065000000	usd
CY2023Q4	jxn	Debt Securities Allowance For Credit Loss DebtSecuritiesAllowanceForCreditLoss	21000000	usd
CY2023Q4	jxn	Debt Securities Accumulated Gross Unrealized Gain Before Tax DebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	259000000	usd
CY2023Q4	jxn	Debt Securities Accumulated Gross Unrealized Loss Before Tax DebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	4660000000	usd
CY2023Q4	us-gaap	Debt Securities DebtSecurities	42643000000	usd
CY2024Q1	jxn	Debt Securities Amortized Cost Maturity Allocated And Single Maturity Date Year One DebtSecuritiesAmortizedCostMaturityAllocatedAndSingleMaturityDateYearOne	2878000000	usd
CY2024Q1	jxn	Debt Securities Allowance For Credit Loss Maturity Allocated And Single Maturity Date Year One DebtSecuritiesAllowanceForCreditLossMaturityAllocatedAndSingleMaturityDateYearOne	0	usd
CY2024Q1	jxn	Debt Securities Accumulated Gross Unrealized Gain Before Tax Maturity Allocated And Single Maturity Date Year One DebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTaxMaturityAllocatedAndSingleMaturityDateYearOne	0	usd
CY2024Q1	jxn	Debt Securities Accumulated Gross Unrealized Loss Before Tax Maturity Allocated And Single Maturity Date Year One DebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTaxMaturityAllocatedAndSingleMaturityDateYearOne	24000000	usd
CY2024Q1	jxn	Debt Securities Fair Value Maturity Allocated And Single Maturity Date Year One DebtSecuritiesFairValueMaturityAllocatedAndSingleMaturityDateYearOne	2854000000	usd
CY2024Q1	jxn	Debt Securities Amortized Cost Maturity Allocated And Single Maturity Date After Year One Through Five DebtSecuritiesAmortizedCostMaturityAllocatedAndSingleMaturityDateAfterYearOneThroughFive	10150000000	usd
CY2024Q1	jxn	Debt Securities Allowance For Credit Loss Maturity Allocated And Single Maturity Date After Year One Through Five DebtSecuritiesAllowanceForCreditLossMaturityAllocatedAndSingleMaturityDateAfterYearOneThroughFive	10000000	usd
CY2024Q1	jxn	Debt Securities Accumulated Gross Unrealized Gain Before Tax Maturity Allocated And Single Maturity Date After Year One Through Year Five DebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTaxMaturityAllocatedAndSingleMaturityDateAfterYearOneThroughYearFive	31000000	usd
CY2024Q1	jxn	Debt Securities Accumulated Gross Unrealized Loss Before Tax Maturity Allocated And Single Maturity Date After Year One Through Year Five DebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTaxMaturityAllocatedAndSingleMaturityDateAfterYearOneThroughYearFive	288000000	usd
CY2024Q1	jxn	Debt Securities Fair Value Maturity Allocated And Single Maturity Date After Year One Through Five DebtSecuritiesFairValueMaturityAllocatedAndSingleMaturityDateAfterYearOneThroughFive	9883000000	usd
CY2024Q1	jxn	Debt Securities Amortized Cost Maturity Allocated And Single Maturity Date After Year Five Through Ten DebtSecuritiesAmortizedCostMaturityAllocatedAndSingleMaturityDateAfterYearFiveThroughTen	11808000000	usd
CY2024Q1	jxn	Debt Securities Allowance For Credit Loss Maturity Allocated And Single Maturity Date After Year Five Through Ten DebtSecuritiesAllowanceForCreditLossMaturityAllocatedAndSingleMaturityDateAfterYearFiveThroughTen	3000000	usd
CY2024Q1	jxn	Debt Securities Accumulated Gross Unrealized Gain Before Tax Maturity Allocated And Single Maturity Date After Year Five Through Year Ten DebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTaxMaturityAllocatedAndSingleMaturityDateAfterYearFiveThroughYearTen	70000000	usd
CY2024Q1	jxn	Debt Securities Accumulated Gross Unrealized Loss Before Tax Maturity Allocated And Single Maturity Date After Year Five Through Year Ten DebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTaxMaturityAllocatedAndSingleMaturityDateAfterYearFiveThroughYearTen	1010000000	usd
CY2024Q1	jxn	Debt Securities Fair Value Maturity Allocated And Single Maturity Date After Year Five Through Ten DebtSecuritiesFairValueMaturityAllocatedAndSingleMaturityDateAfterYearFiveThroughTen	10865000000	usd
CY2024Q1	jxn	Debt Securities Amortized Cost Maturity Allocated And Single Maturity Date After Year Ten Through Twenty DebtSecuritiesAmortizedCostMaturityAllocatedAndSingleMaturityDateAfterYearTenThroughTwenty	8582000000	usd
CY2024Q1	jxn	Debt Securities Allowance For Credit Loss Maturity Allocated And Single Maturity Date After Year Ten Through Twenty DebtSecuritiesAllowanceForCreditLossMaturityAllocatedAndSingleMaturityDateAfterYearTenThroughTwenty	0	usd
CY2024Q1	jxn	Debt Securities Accumulated Gross Unrealized Gain Before Tax Maturity Allocated And Single Maturity Date After Year Ten Through Year Twenty DebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTaxMaturityAllocatedAndSingleMaturityDateAfterYearTenThroughYearTwenty	57000000	usd
CY2024Q1	jxn	Debt Securities Accumulated Gross Unrealized Loss Before Tax Maturity Allocated And Single Maturity Date After Year Ten Through Year Twenty DebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTaxMaturityAllocatedAndSingleMaturityDateAfterYearTenThroughYearTwenty	1402000000	usd
CY2024Q1	jxn	Debt Securities Fair Value Maturity Allocated And Single Maturity Date After Year Ten Through Twenty DebtSecuritiesFairValueMaturityAllocatedAndSingleMaturityDateAfterYearTenThroughTwenty	7237000000	usd
CY2024Q1	jxn	Debt Securities Amortized Cost Maturity Allocated And Single Maturity Date After Year Twenty DebtSecuritiesAmortizedCostMaturityAllocatedAndSingleMaturityDateAfterYearTwenty	6877000000	usd
CY2024Q1	jxn	Debt Securities Allowance For Credit Loss Maturity Allocated And Single Maturity Date After Year Twenty DebtSecuritiesAllowanceForCreditLossMaturityAllocatedAndSingleMaturityDateAfterYearTwenty	0	usd
CY2024Q1	jxn	Debt Securities Accumulated Gross Unrealized Gain Before Tax Maturity Allocated And Single Maturity Date After Year Twenty DebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTaxMaturityAllocatedAndSingleMaturityDateAfterYearTwenty	10000000	usd
CY2024Q1	jxn	Debt Securities Accumulated Gross Unrealized Loss Before Tax Maturity Allocated And Single Maturity Date After Year Twenty DebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTaxMaturityAllocatedAndSingleMaturityDateAfterYearTwenty	1692000000	usd
CY2024Q1	jxn	Debt Securities Fair Value Maturity Allocated And Single Maturity Date After Year Twenty DebtSecuritiesFairValueMaturityAllocatedAndSingleMaturityDateAfterYearTwenty	5195000000	usd
CY2024Q1	jxn	Debt Securities Amortized Cost DebtSecuritiesAmortizedCost	47122000000	usd
CY2024Q1	jxn	Debt Securities Allowance For Credit Loss DebtSecuritiesAllowanceForCreditLoss	20000000	usd
CY2024Q1	jxn	Debt Securities Accumulated Gross Unrealized Gain Before Tax DebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	188000000	usd
CY2024Q1	jxn	Debt Securities Accumulated Gross Unrealized Loss Before Tax DebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	4874000000	usd
CY2024Q1	us-gaap	Debt Securities DebtSecurities	42416000000	usd
CY2024Q1	us-gaap	Securities Reserve Deposit Required And Made SecuritiesReserveDepositRequiredAndMade	88000000	usd
CY2023Q4	us-gaap	Securities Reserve Deposit Required And Made SecuritiesReserveDepositRequiredAndMade	91000000	usd
CY2024Q1	jxn	Debt Securities Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss DebtSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss	188000000	usd
CY2024Q1	jxn	Debt Securities Continuous Unrealized Loss Position Less Than12 Months DebtSecuritiesContinuousUnrealizedLossPositionLessThan12Months	4793000000	usd
CY2024Q1	jxn	Debt Securities Continuous Unrealized Loss Position Less Than12 Months Number Of Positions DebtSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions	573	security
CY2023Q4	jxn	Debt Securities Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss DebtSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss	143000000	usd
CY2023Q4	jxn	Debt Securities Continuous Unrealized Loss Position Less Than12 Months DebtSecuritiesContinuousUnrealizedLossPositionLessThan12Months	2776000000	usd
CY2023Q4	jxn	Debt Securities Continuous Unrealized Loss Position Less Than12 Months Number Of Positions DebtSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions	385	security
CY2024Q1	jxn	Debt Securities Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss DebtSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss	4686000000	usd
CY2024Q1	jxn	Debt Securities Continuous Unrealized Loss Position12 Months Or Longer DebtSecuritiesContinuousUnrealizedLossPosition12MonthsOrLonger	28554000000	usd
CY2024Q1	jxn	Debt Securities Continuous Unrealized Loss Position12 Months Or Longer Number Of Positions DebtSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions	3525	security
CY2023Q4	jxn	Debt Securities Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss DebtSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss	4517000000	usd
CY2023Q4	jxn	Debt Securities Continuous Unrealized Loss Position12 Months Or Longer DebtSecuritiesContinuousUnrealizedLossPosition12MonthsOrLonger	30323000000	usd
CY2023Q4	jxn	Debt Securities Continuous Unrealized Loss Position12 Months Or Longer Number Of Positions DebtSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions	3695	security
CY2024Q1	jxn	Debt Securities Unrealized Loss Position Accumulated Loss DebtSecuritiesUnrealizedLossPositionAccumulatedLoss	4874000000	usd
CY2024Q1	jxn	Debt Securities Unrealized Loss Position DebtSecuritiesUnrealizedLossPosition	33347000000	usd
CY2024Q1	jxn	Debt Securities Unrealized Loss Position Number Of Positions DebtSecuritiesUnrealizedLossPositionNumberOfPositions	3961	security
CY2023Q4	jxn	Debt Securities Unrealized Loss Position Accumulated Loss DebtSecuritiesUnrealizedLossPositionAccumulatedLoss	4660000000	usd
CY2023Q4	jxn	Debt Securities Unrealized Loss Position DebtSecuritiesUnrealizedLossPosition	33099000000	usd
CY2023Q4	jxn	Debt Securities Unrealized Loss Position Number Of Positions DebtSecuritiesUnrealizedLossPositionNumberOfPositions	3968	security
CY2024Q1	jxn	Debt Securities Available For Sale Accrued Interest After Allowance For Credit Loss Statement Of Financial Position Extensible List Not Disclosed Flag DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLossStatementOfFinancialPositionExtensibleListNotDisclosedFlag	Accrued interest receivables
CY2023Q1	jxn	Debt Securities Available For Sale Accrued Interest After Allowance For Credit Loss Statement Of Financial Position Extensible List Not Disclosed Flag DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLossStatementOfFinancialPositionExtensibleListNotDisclosedFlag	Accrued interest receivables
CY2024Q1	jxn	Debt Securities Available For Sale Accrued Interest Allowance For Credit Loss Writeoff DebtSecuritiesAvailableForSaleAccruedInterestAllowanceForCreditLossWriteoff	0	usd
CY2023Q1	jxn	Debt Securities Available For Sale Accrued Interest Allowance For Credit Loss Writeoff DebtSecuritiesAvailableForSaleAccruedInterestAllowanceForCreditLossWriteoff	0	usd
CY2023Q4	us-gaap	Debt Securities Available For Sale Amortized Cost Allowance For Credit Loss Excluding Accrued Interest DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest	21000000	usd
CY2024Q1	us-gaap	Debt Securities Available For Sale Excluding Accrued Interest Allowance For Credit Loss Not Previously Recorded DebtSecuritiesAvailableForSaleExcludingAccruedInterestAllowanceForCreditLossNotPreviouslyRecorded	1000000	usd
CY2024Q1	us-gaap	Debt Securities Available For Sale Excluding Accrued Interest Allowance For Credit Loss Not To Sell Before Recovery Credit Loss Previously Recorded Expense Reversal DebtSecuritiesAvailableForSaleExcludingAccruedInterestAllowanceForCreditLossNotToSellBeforeRecoveryCreditLossPreviouslyRecordedExpenseReversal	0	usd
CY2024Q1	us-gaap	Debt Securities Available For Sale Excluding Accrued Interest Purchased With Credit Deterioration Allowance For Credit Loss At Acquisition Date DebtSecuritiesAvailableForSaleExcludingAccruedInterestPurchasedWithCreditDeteriorationAllowanceForCreditLossAtAcquisitionDate	0	usd
CY2024Q1	us-gaap	Debt Securities Available For Sale Excluding Accrued Interest Allowance For Credit Loss Writeoff DebtSecuritiesAvailableForSaleExcludingAccruedInterestAllowanceForCreditLossWriteoff	0	usd
CY2024Q1	us-gaap	Debt Securities Available For Sale Excluding Accrued Interest Allowance For Credit Loss Securities Sold DebtSecuritiesAvailableForSaleExcludingAccruedInterestAllowanceForCreditLossSecuritiesSold	2000000	usd
CY2024Q1	us-gaap	Debt Securities Available For Sale Excluding Accrued Interest Allowance For Credit Loss Sell Before Recovery DebtSecuritiesAvailableForSaleExcludingAccruedInterestAllowanceForCreditLossSellBeforeRecovery	0	usd
CY2024Q1	us-gaap	Debt Securities Available For Sale Amortized Cost Allowance For Credit Loss Excluding Accrued Interest DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest	20000000	usd
CY2022Q4	us-gaap	Debt Securities Available For Sale Amortized Cost Allowance For Credit Loss Excluding Accrued Interest DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest	23000000	usd
CY2023Q1	us-gaap	Debt Securities Available For Sale Excluding Accrued Interest Allowance For Credit Loss Not Previously Recorded DebtSecuritiesAvailableForSaleExcludingAccruedInterestAllowanceForCreditLossNotPreviouslyRecorded	32000000	usd
CY2023Q1	us-gaap	Debt Securities Available For Sale Excluding Accrued Interest Allowance For Credit Loss Not To Sell Before Recovery Credit Loss Previously Recorded Expense Reversal DebtSecuritiesAvailableForSaleExcludingAccruedInterestAllowanceForCreditLossNotToSellBeforeRecoveryCreditLossPreviouslyRecordedExpenseReversal	1000000	usd
CY2023Q1	us-gaap	Debt Securities Available For Sale Excluding Accrued Interest Purchased With Credit Deterioration Allowance For Credit Loss At Acquisition Date DebtSecuritiesAvailableForSaleExcludingAccruedInterestPurchasedWithCreditDeteriorationAllowanceForCreditLossAtAcquisitionDate	0	usd
CY2023Q1	us-gaap	Debt Securities Available For Sale Excluding Accrued Interest Allowance For Credit Loss Writeoff DebtSecuritiesAvailableForSaleExcludingAccruedInterestAllowanceForCreditLossWriteoff	0	usd
CY2023Q1	us-gaap	Debt Securities Available For Sale Excluding Accrued Interest Allowance For Credit Loss Securities Sold DebtSecuritiesAvailableForSaleExcludingAccruedInterestAllowanceForCreditLossSecuritiesSold	10000000	usd
CY2023Q1	us-gaap	Debt Securities Available For Sale Excluding Accrued Interest Allowance For Credit Loss Sell Before Recovery DebtSecuritiesAvailableForSaleExcludingAccruedInterestAllowanceForCreditLossSellBeforeRecovery	17000000	usd
CY2023Q1	us-gaap	Debt Securities Available For Sale Amortized Cost Allowance For Credit Loss Excluding Accrued Interest DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest	29000000	usd
CY2024Q1	us-gaap	Debt Securities Available For Sale Accrued Interest After Allowance For Credit Loss DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLoss	403000000	usd
CY2023Q1	us-gaap	Debt Securities Available For Sale Accrued Interest After Allowance For Credit Loss DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLoss	413000000	usd
CY2024Q1	us-gaap	Investment Income Investment Expense InvestmentIncomeInvestmentExpense	122000000	usd
CY2023Q1	us-gaap	Investment Income Investment Expense InvestmentIncomeInvestmentExpense	130000000	usd
CY2024Q1	jxn	Net Investment Income Excluding Funds Withheld Assets NetInvestmentIncomeExcludingFundsWithheldAssets	464000000	usd
CY2023Q1	jxn	Net Investment Income Excluding Funds Withheld Assets NetInvestmentIncomeExcludingFundsWithheldAssets	400000000	usd
CY2024Q1	us-gaap	Net Investment Income NetInvestmentIncome	734000000	usd
CY2023Q1	us-gaap	Net Investment Income NetInvestmentIncome	707000000	usd
CY2024Q1	us-gaap	Debt Securities Available For Sale Realized Gain DebtSecuritiesAvailableForSaleRealizedGain	13000000	usd
CY2023Q1	us-gaap	Debt Securities Available For Sale Realized Gain DebtSecuritiesAvailableForSaleRealizedGain	4000000	usd
CY2024Q1	us-gaap	Debt Securities Available For Sale Realized Loss DebtSecuritiesAvailableForSaleRealizedLoss	81000000	usd
CY2023Q1	us-gaap	Debt Securities Available For Sale Realized Loss DebtSecuritiesAvailableForSaleRealizedLoss	25000000	usd
CY2024Q1	jxn	Debt Securities Available For Sale Credit Loss Expense Reversal DebtSecuritiesAvailableForSaleCreditLossExpenseReversal	0	usd
CY2023Q1	jxn	Debt Securities Available For Sale Credit Loss Expense Reversal DebtSecuritiesAvailableForSaleCreditLossExpenseReversal	11000000	usd
CY2024Q1	jxn	Financing Receivable Credit Loss Expense Reversal And Other Gain Loss FinancingReceivableCreditLossExpenseReversalAndOtherGainLoss	4000000	usd
CY2023Q1	jxn	Financing Receivable Credit Loss Expense Reversal And Other Gain Loss FinancingReceivableCreditLossExpenseReversalAndOtherGainLoss	47000000	usd
CY2024Q1	jxn	Other Operating Gain Loss OtherOperatingGainLoss	65000000	usd
CY2023Q1	jxn	Other Operating Gain Loss OtherOperatingGainLoss	11000000	usd
CY2024Q1	us-gaap	Gain Loss On Investments GainLossOnInvestments	-7000000	usd
CY2023Q1	us-gaap	Gain Loss On Investments GainLossOnInvestments	-68000000	usd
CY2024Q1	jxn	Gain Loss On Investments And Derivative Instruments GainLossOnInvestmentsAndDerivativeInstruments	-2892000000	usd
CY2023Q1	jxn	Gain Loss On Investments And Derivative Instruments GainLossOnInvestmentsAndDerivativeInstruments	-2726000000	usd
CY2024Q1	jxn	Gain Loss On Investments And Derivative Instruments Net GainLossOnInvestmentsAndDerivativeInstrumentsNet	-3093000000	usd
CY2023Q1	jxn	Gain Loss On Investments And Derivative Instruments Net GainLossOnInvestmentsAndDerivativeInstrumentsNet	-3399000000	usd
CY2024Q1	jxn	Aggregate Fair Value Of Securities Sold At A Loss AggregateFairValueOfSecuritiesSoldAtALoss	1270000000	usd
CY2023Q1	jxn	Aggregate Fair Value Of Securities Sold At A Loss AggregateFairValueOfSecuritiesSoldAtALoss	1797000000	usd
CY2024Q1	jxn	Aggregate Fair Value Of Securities Sold At A Loss Percentage Of Book Value AggregateFairValueOfSecuritiesSoldAtALossPercentageOfBookValue	0.93
CY2023Q1	jxn	Aggregate Fair Value Of Securities Sold At A Loss Percentage Of Book Value AggregateFairValueOfSecuritiesSoldAtALossPercentageOfBookValue	0.97
CY2024Q1	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	1700000000	usd
CY2023Q1	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	2100000000	usd
CY2023Q4	us-gaap	Secured Debt SecuredDebt	97000000	usd
CY2024Q1	us-gaap	Secured Debt SecuredDebt	37000000	usd
CY2023	us-gaap	Equity Method Investment Realized Gain Loss On Disposal EquityMethodInvestmentRealizedGainLossOnDisposal	-97000000	usd
CY2024Q1	us-gaap	Variable Interest Entity Entity Maximum Loss Exposure Amount VariableInterestEntityEntityMaximumLossExposureAmount	2578000000	usd
CY2023Q4	us-gaap	Variable Interest Entity Entity Maximum Loss Exposure Amount VariableInterestEntityEntityMaximumLossExposureAmount	2576000000	usd
CY2023Q4	us-gaap	Financing Receivable Allowance For Credit Loss Excluding Accrued Interest FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest	165000000	usd
CY2024Q1	us-gaap	Financing Receivable Excluding Accrued Interest Allowance For Credit Loss Writeoff After Recovery FinancingReceivableExcludingAccruedInterestAllowanceForCreditLossWriteoffAfterRecovery	0	usd
CY2024Q1	us-gaap	Financing Receivable Allowance For Credit Loss Purchased With Credit Deterioration Increase FinancingReceivableAllowanceForCreditLossPurchasedWithCreditDeteriorationIncrease	0	usd
CY2024Q1	us-gaap	Financing Receivable Excluding Accrued Interest Credit Loss Expense Reversal FinancingReceivableExcludingAccruedInterestCreditLossExpenseReversal	-3000000	usd
CY2024Q1	us-gaap	Financing Receivable Allowance For Credit Loss Excluding Accrued Interest FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest	162000000	usd
CY2022Q4	us-gaap	Financing Receivable Allowance For Credit Loss Excluding Accrued Interest FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest	95000000	usd
CY2023Q1	us-gaap	Financing Receivable Excluding Accrued Interest Allowance For Credit Loss Writeoff After Recovery FinancingReceivableExcludingAccruedInterestAllowanceForCreditLossWriteoffAfterRecovery	0	usd
CY2023Q1	us-gaap	Financing Receivable Allowance For Credit Loss Purchased With Credit Deterioration Increase FinancingReceivableAllowanceForCreditLossPurchasedWithCreditDeteriorationIncrease	0	usd
CY2023Q1	us-gaap	Financing Receivable Excluding Accrued Interest Credit Loss Expense Reversal FinancingReceivableExcludingAccruedInterestCreditLossExpenseReversal	51000000	usd
CY2023Q1	us-gaap	Financing Receivable Allowance For Credit Loss Excluding Accrued Interest FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest	146000000	usd
CY2024Q1	us-gaap	Financing Receivable Accrued Interest After Allowance For Credit Loss FinancingReceivableAccruedInterestAfterAllowanceForCreditLoss	47000000	usd
CY2023Q1	us-gaap	Financing Receivable Accrued Interest After Allowance For Credit Loss FinancingReceivableAccruedInterestAfterAllowanceForCreditLoss	47000000	usd
CY2024Q1	us-gaap	Impaired Financing Receivable Recorded Investment ImpairedFinancingReceivableRecordedInvestment	23000000	usd
CY2023Q4	us-gaap	Impaired Financing Receivable Recorded Investment ImpairedFinancingReceivableRecordedInvestment	24000000	usd
CY2024Q1	us-gaap	Impaired Financing Receivable Unpaid Principal Balance ImpairedFinancingReceivableUnpaidPrincipalBalance	26000000	usd
CY2023Q4	us-gaap	Impaired Financing Receivable Unpaid Principal Balance ImpairedFinancingReceivableUnpaidPrincipalBalance	27000000	usd
CY2024Q1	us-gaap	Impaired Financing Receivable Related Allowance ImpairedFinancingReceivableRelatedAllowance	1000000	usd
CY2023Q4	us-gaap	Impaired Financing Receivable Related Allowance ImpairedFinancingReceivableRelatedAllowance	1000000	usd
CY2024Q1	us-gaap	Impaired Financing Receivable Average Recorded Investment ImpairedFinancingReceivableAverageRecordedInvestment	21000000	usd
CY2023	us-gaap	Impaired Financing Receivable Average Recorded Investment ImpairedFinancingReceivableAverageRecordedInvestment	19000000	usd
CY2024Q1	us-gaap	Impaired Financing Receivable With Related Allowance Interest Income Accrual Method ImpairedFinancingReceivableWithRelatedAllowanceInterestIncomeAccrualMethod	0	usd
CY2023	us-gaap	Impaired Financing Receivable With Related Allowance Interest Income Accrual Method ImpairedFinancingReceivableWithRelatedAllowanceInterestIncomeAccrualMethod	1000000	usd
CY2024Q1	us-gaap	Financing Receivable Excluding Accrued Interest Year One Originated Current Fiscal Year FinancingReceivableExcludingAccruedInterestYearOneOriginatedCurrentFiscalYear	100000000	usd
CY2024Q1	us-gaap	Financing Receivable Excluding Accrued Interest Year Two Originated Fiscal Year Before Current Fiscal Year FinancingReceivableExcludingAccruedInterestYearTwoOriginatedFiscalYearBeforeCurrentFiscalYear	880000000	usd
CY2024Q1	us-gaap	Financing Receivable Excluding Accrued Interest Year Three Originated Two Years Before Current Fiscal Year FinancingReceivableExcludingAccruedInterestYearThreeOriginatedTwoYearsBeforeCurrentFiscalYear	1107000000	usd
CY2024Q1	us-gaap	Financing Receivable Excluding Accrued Interest Year Four Originated Three Years Before Current Fiscal Year FinancingReceivableExcludingAccruedInterestYearFourOriginatedThreeYearsBeforeCurrentFiscalYear	1396000000	usd
CY2024Q1	us-gaap	Financing Receivable Excluding Accrued Interest Year Five Originated Four Years Before Current Fiscal Year FinancingReceivableExcludingAccruedInterestYearFiveOriginatedFourYearsBeforeCurrentFiscalYear	779000000	usd
CY2024Q1	us-gaap	Financing Receivable Excluding Accrued Interest Originated More Than Five Years Before Current Fiscal Year FinancingReceivableExcludingAccruedInterestOriginatedMoreThanFiveYearsBeforeCurrentFiscalYear	6088000000	usd
CY2024Q1	us-gaap	Financing Receivable Excluding Accrued Interest Revolving FinancingReceivableExcludingAccruedInterestRevolving	4000000	usd
CY2024Q1	us-gaap	Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss	10354000000	usd
CY2024Q1	srt	Financing Receivable Before Allowance For Credit Loss To Total Percent FinancingReceivableBeforeAllowanceForCreditLossToTotalPercent	1
CY2023Q4	us-gaap	Financing Receivable Excluding Accrued Interest Year One Originated Current Fiscal Year FinancingReceivableExcludingAccruedInterestYearOneOriginatedCurrentFiscalYear	879000000	usd
CY2023Q4	us-gaap	Financing Receivable Excluding Accrued Interest Year Two Originated Fiscal Year Before Current Fiscal Year FinancingReceivableExcludingAccruedInterestYearTwoOriginatedFiscalYearBeforeCurrentFiscalYear	1140000000	usd
CY2023Q4	us-gaap	Financing Receivable Excluding Accrued Interest Year Three Originated Two Years Before Current Fiscal Year FinancingReceivableExcludingAccruedInterestYearThreeOriginatedTwoYearsBeforeCurrentFiscalYear	1453000000	usd
CY2023Q4	us-gaap	Financing Receivable Excluding Accrued Interest Year Four Originated Three Years Before Current Fiscal Year FinancingReceivableExcludingAccruedInterestYearFourOriginatedThreeYearsBeforeCurrentFiscalYear	855000000	usd
CY2023Q4	us-gaap	Financing Receivable Excluding Accrued Interest Year Five Originated Four Years Before Current Fiscal Year FinancingReceivableExcludingAccruedInterestYearFiveOriginatedFourYearsBeforeCurrentFiscalYear	1408000000	usd
CY2023Q4	us-gaap	Financing Receivable Excluding Accrued Interest Originated More Than Five Years Before Current Fiscal Year FinancingReceivableExcludingAccruedInterestOriginatedMoreThanFiveYearsBeforeCurrentFiscalYear	4824000000	usd
CY2023Q4	us-gaap	Financing Receivable Excluding Accrued Interest Revolving FinancingReceivableExcludingAccruedInterestRevolving	4000000	usd
CY2023Q4	us-gaap	Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss	10563000000	usd
CY2023Q4	srt	Financing Receivable Before Allowance For Credit Loss To Total Percent FinancingReceivableBeforeAllowanceForCreditLossToTotalPercent	1
CY2024Q1	us-gaap	Financing Receivable Modifications Recorded Investment FinancingReceivableModificationsRecordedInvestment	43000000	usd
CY2024Q1	us-gaap	Mortgage Loans In Process Of Foreclosure Amount MortgageLoansInProcessOfForeclosureAmount	23000000	usd
CY2024Q1	us-gaap	Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss	10354000000	usd
CY2023Q4	us-gaap	Financing Receivable Modifications Recorded Investment FinancingReceivableModificationsRecordedInvestment	0	usd
CY2023Q4	us-gaap	Mortgage Loans In Process Of Foreclosure Amount MortgageLoansInProcessOfForeclosureAmount	24000000	usd
CY2023Q4	us-gaap	Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss	10563000000	usd
CY2024Q1	jxn	Financing Receivable Stressed Loans FinancingReceivableStressedLoans	19000000	usd
CY2023Q1	jxn	Financing Receivable Stressed Loans FinancingReceivableStressedLoans	4000000	usd
CY2024Q1	jxn	Loans Gross Insurance Policy Fair Value Option LoansGrossInsurancePolicyFairValueOption	3400000000	usd
CY2023Q4	jxn	Loans Gross Insurance Policy Fair Value Option LoansGrossInsurancePolicyFairValueOption	3500000000	usd
CY2024Q1	jxn	Loans Gross Insurance Policy Not Held As Collateral LoansGrossInsurancePolicyNotHeldAsCollateral	900000000	usd
CY2023Q4	jxn	Loans Gross Insurance Policy Not Held As Collateral LoansGrossInsurancePolicyNotHeldAsCollateral	900000000	usd
CY2024Q1	jxn	Securities Loaned Fair Value Disclosure SecuritiesLoanedFairValueDisclosure	20000000	usd
CY2023Q4	jxn	Securities Loaned Fair Value Disclosure SecuritiesLoanedFairValueDisclosure	19000000	usd
CY2024Q1	jxn	Securities Loaned Minimum Fair Value Collateral Percent SecuritiesLoanedMinimumFairValueCollateralPercent	1.02
CY2024Q1	us-gaap	Securities Loaned Fair Value Of Collateral SecuritiesLoanedFairValueOfCollateral	21000000	usd
CY2023Q4	us-gaap	Securities Loaned Fair Value Of Collateral SecuritiesLoanedFairValueOfCollateral	19000000	usd
CY2024Q1	us-gaap	Securities Sold Under Agreements To Repurchase SecuritiesSoldUnderAgreementsToRepurchase	1800000000	usd
CY2023Q4	us-gaap	Securities Sold Under Agreements To Repurchase SecuritiesSoldUnderAgreementsToRepurchase	0	usd
CY2024Q1	us-gaap	Interest Income Securities Us Treasury And Other Us Government InterestIncomeSecuritiesUSTreasuryAndOtherUSGovernment	1800000000	usd
CY2023	us-gaap	Interest Income Securities Us Treasury And Other Us Government InterestIncomeSecuritiesUSTreasuryAndOtherUSGovernment	0	usd
CY2024Q1	jxn	Security Sold Under Agreement To Repurchase Collateral Upgrade Subject To Master Netting Arrangement Before Offset SecuritySoldUnderAgreementToRepurchaseCollateralUpgradeSubjectToMasterNettingArrangementBeforeOffset	1500000000	usd
CY2023Q4	jxn	Security Sold Under Agreement To Repurchase Collateral Upgrade Subject To Master Netting Arrangement Before Offset SecuritySoldUnderAgreementToRepurchaseCollateralUpgradeSubjectToMasterNettingArrangementBeforeOffset	0	usd
CY2024Q1	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	-2842000000	usd
CY2023Q1	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	-3037000000	usd
CY2024Q1	jxn	Derivative Assets By Counterparty DerivativeAssetsByCounterparty	108000000	usd
CY2023Q4	jxn	Derivative Assets By Counterparty DerivativeAssetsByCounterparty	117000000	usd
CY2024Q1	us-gaap	Derivative Asset Fair Value Of Collateral DerivativeAssetFairValueOfCollateral	92000000	usd
CY2023Q4	us-gaap	Derivative Asset Fair Value Of Collateral DerivativeAssetFairValueOfCollateral	841000000	usd
CY2024Q1	jxn	Derivative Liabilities By Counterparty DerivativeLiabilitiesByCounterparty	1183000000	usd
CY2023Q4	jxn	Derivative Liabilities By Counterparty DerivativeLiabilitiesByCounterparty	937000000	usd
CY2024Q1	us-gaap	Derivative Liability Fair Value Of Collateral DerivativeLiabilityFairValueOfCollateral	1382000000	usd
CY2023Q4	us-gaap	Derivative Liability Fair Value Of Collateral DerivativeLiabilityFairValueOfCollateral	751000000	usd
CY2024Q1	jxn	Derivative Downgrade Provision Triggered Disbursement Obligation DerivativeDowngradeProvisionTriggeredDisbursementObligation	0	usd
CY2023Q4	jxn	Derivative Downgrade Provision Triggered Disbursement Obligation DerivativeDowngradeProvisionTriggeredDisbursementObligation	910000000	usd
CY2024Q1	jxn	Derivative Claim DerivativeClaim	215000000	usd
CY2023Q4	jxn	Derivative Claim DerivativeClaim	0	usd
CY2024Q1	jxn	Derivative Asset Pledged Collateral DerivativeAssetPledgedCollateral	2294000000	usd
CY2023Q4	jxn	Derivative Asset Pledged Collateral DerivativeAssetPledgedCollateral	2616000000	usd
CY2024Q1	us-gaap	Derivative Fair Value Of Derivative Asset DerivativeFairValueOfDerivativeAsset	213000000	usd
CY2024Q1	us-gaap	Derivative Asset Fair Value Gross Liability DerivativeAssetFairValueGrossLiability	0	usd
CY2024Q1	us-gaap	Derivative Assets DerivativeAssets	213000000	usd
CY2024Q1	us-gaap	Derivative Asset Not Offset Policy Election Deduction DerivativeAssetNotOffsetPolicyElectionDeduction	105000000	usd
CY2024Q1	us-gaap	Derivative Collateral Obligation To Return Cash DerivativeCollateralObligationToReturnCash	91000000	usd
CY2024Q1	us-gaap	Derivative Collateral Obligation To Return Securities DerivativeCollateralObligationToReturnSecurities	0	usd
CY2024Q1	us-gaap	Derivative Fair Value Of Derivative Asset Amount Offset Against Collateral DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral	17000000	usd
CY2024Q1	us-gaap	Derivative Fair Value Of Derivative Liability Amount Not Offset Against Collateral DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral	1288000000	usd
CY2024Q1	us-gaap	Derivative Liability Fair Value Gross Asset DerivativeLiabilityFairValueGrossAsset	0	usd
CY2024Q1	us-gaap	Derivative Liabilities DerivativeLiabilities	1288000000	usd
CY2024Q1	us-gaap	Derivative Liability Not Offset Policy Election Deduction DerivativeLiabilityNotOffsetPolicyElectionDeduction	105000000	usd
CY2024Q1	us-gaap	Derivative Collateral Right To Reclaim Cash DerivativeCollateralRightToReclaimCash	0	usd
CY2024Q1	us-gaap	Derivative Collateral Right To Reclaim Securities DerivativeCollateralRightToReclaimSecurities	1182000000	usd
CY2024Q1	us-gaap	Derivative Fair Value Of Derivative Liability Amount Offset Against Collateral DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral	1000000	usd
CY2024Q1	us-gaap	Securities Loaned Gross SecuritiesLoanedGross	21000000	usd
CY2024Q1	us-gaap	Securities Loaned Asset SecuritiesLoanedAsset	0	usd
CY2024Q1	us-gaap	Securities Loaned SecuritiesLoaned	21000000	usd
CY2024Q1	us-gaap	Securities Loaned Not Offset Policy Election Deduction SecuritiesLoanedNotOffsetPolicyElectionDeduction	0	usd
CY2024Q1	us-gaap	Securities Loaned Collateral Right To Reclaim Cash SecuritiesLoanedCollateralRightToReclaimCash	21000000	usd
CY2024Q1	us-gaap	Securities Loaned Collateral Right To Reclaim Securities SecuritiesLoanedCollateralRightToReclaimSecurities	0	usd
CY2024Q1	us-gaap	Securities Loaned Amount Offset Against Collateral SecuritiesLoanedAmountOffsetAgainstCollateral	0	usd
CY2024Q1	us-gaap	Securities Sold Under Agreements To Repurchase Gross SecuritiesSoldUnderAgreementsToRepurchaseGross	1799000000	usd
CY2024Q1	us-gaap	Securities Sold Under Agreements To Repurchase Asset SecuritiesSoldUnderAgreementsToRepurchaseAsset	0	usd
CY2024Q1	us-gaap	Securities Sold Under Agreements To Repurchase SecuritiesSoldUnderAgreementsToRepurchase	1799000000	usd
CY2024Q1	us-gaap	Securities Sold Under Agreements To Resell Not Offset Policy Election Deduction SecuritiesSoldUnderAgreementsToResellNotOffsetPolicyElectionDeduction	0	usd
CY2024Q1	us-gaap	Securities Sold Under Agreements To Repurchase Collateral Right To Reclaim Cash SecuritiesSoldUnderAgreementsToRepurchaseCollateralRightToReclaimCash	0	usd
CY2024Q1	us-gaap	Securities Sold Under Agreements To Repurchase Collateral Right To Reclaim Securities SecuritiesSoldUnderAgreementsToRepurchaseCollateralRightToReclaimSecurities	1799000000	usd
CY2024Q1	us-gaap	Securities Sold Under Agreements To Repurchase Amount Offset Against Collateral SecuritiesSoldUnderAgreementsToRepurchaseAmountOffsetAgainstCollateral	0	usd
CY2024Q1	jxn	Security Sold Under Agreement To Repurchase Collateral Upgrade Subject To Master Netting Arrangement Before Offset SecuritySoldUnderAgreementToRepurchaseCollateralUpgradeSubjectToMasterNettingArrangementBeforeOffset	1498000000	usd
CY2024Q1	jxn	Security Sold Under Agreement To Repurchase Collateral Upgrade Subject To Master Netting Arrangement Asset Offset SecuritySoldUnderAgreementToRepurchaseCollateralUpgradeSubjectToMasterNettingArrangementAssetOffset	1498000000	usd
CY2024Q1	jxn	Securities Sold Under Agreements To Repurchase Collateral Upgrade SecuritiesSoldUnderAgreementsToRepurchaseCollateralUpgrade	0	usd
CY2024Q1	jxn	Security Sold Under Agreement To Repurchase Subject To Master Netting Arrangement Collateral Upgrade Deduction Of Financial Instrument Not Offset SecuritySoldUnderAgreementToRepurchaseSubjectToMasterNettingArrangementCollateralUpgradeDeductionOfFinancialInstrumentNotOffset	0	usd
CY2024Q1	jxn	Security Sold Under Agreement To Repurchase Subject To Master Netting Arrangement Collateral Upgrade Collateral Right To Reclaim Cash Not Offset SecuritySoldUnderAgreementToRepurchaseSubjectToMasterNettingArrangementCollateralUpgradeCollateralRightToReclaimCashNotOffset	0	usd
CY2024Q1	jxn	Security Sold Under Agreement To Repurchase Subject To Master Netting Arrangement Collateral Upgrade Collateral Right To Reclaim Security Not Offset SecuritySoldUnderAgreementToRepurchaseSubjectToMasterNettingArrangementCollateralUpgradeCollateralRightToReclaimSecurityNotOffset	0	usd
CY2024Q1	jxn	Security Sold Under Agreement To Repurchase Including Not Subject To Master Netting Arrangement Collateral Upgrade After Offset And Deduction SecuritySoldUnderAgreementToRepurchaseIncludingNotSubjectToMasterNettingArrangementCollateralUpgradeAfterOffsetAndDeduction	0	usd
CY2024Q1	us-gaap	Derivative Liability Securities Sold Under Agreements To Resell Securities Loaned Gross DerivativeLiabilitySecuritiesSoldUnderAgreementsToResellSecuritiesLoanedGross	4606000000	usd
CY2024Q1	us-gaap	Derivative Liability Securities Sold Under Agreements To Resell Securities Loaned Asset DerivativeLiabilitySecuritiesSoldUnderAgreementsToResellSecuritiesLoanedAsset	1498000000	usd
CY2024Q1	us-gaap	Derivative Liability Securities Sold Under Agreements To Resell Securities Loaned DerivativeLiabilitySecuritiesSoldUnderAgreementsToResellSecuritiesLoaned	3108000000	usd
CY2024Q1	us-gaap	Derivative Liability Securities Sold Under Agreements To Resell Securities Loaned Not Offset Policy Election Deduction DerivativeLiabilitySecuritiesSoldUnderAgreementsToResellSecuritiesLoanedNotOffsetPolicyElectionDeduction	105000000	usd
CY2024Q1	us-gaap	Derivative Liability Securities Sold Under Agreements To Resell Securities Loaned Collateral Right To Reclaim Cash DerivativeLiabilitySecuritiesSoldUnderAgreementsToResellSecuritiesLoanedCollateralRightToReclaimCash	21000000	usd
CY2024Q1	us-gaap	Derivative Liability Securities Sold Under Agreements To Resell Securities Loaned Collateral Right To Reclaim Securities DerivativeLiabilitySecuritiesSoldUnderAgreementsToResellSecuritiesLoanedCollateralRightToReclaimSecurities	2981000000	usd
CY2024Q1	us-gaap	Derivative Liability Securities Sold Under Agreements To Resell Securities Loaned Amount Offset Against Collateral DerivativeLiabilitySecuritiesSoldUnderAgreementsToResellSecuritiesLoanedAmountOffsetAgainstCollateral	1000000	usd
CY2023Q4	us-gaap	Derivative Fair Value Of Derivative Asset DerivativeFairValueOfDerivativeAsset	390000000	usd
CY2023Q4	us-gaap	Derivative Asset Fair Value Gross Liability DerivativeAssetFairValueGrossLiability	0	usd
CY2023Q4	us-gaap	Derivative Assets DerivativeAssets	390000000	usd
CY2023Q4	us-gaap	Derivative Asset Not Offset Policy Election Deduction DerivativeAssetNotOffsetPolicyElectionDeduction	273000000	usd
CY2023Q4	us-gaap	Derivative Collateral Obligation To Return Cash DerivativeCollateralObligationToReturnCash	108000000	usd
CY2023Q4	us-gaap	Derivative Collateral Obligation To Return Securities DerivativeCollateralObligationToReturnSecurities	0	usd
CY2023Q4	us-gaap	Derivative Fair Value Of Derivative Asset Amount Offset Against Collateral DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral	9000000	usd
CY2023Q4	us-gaap	Derivative Fair Value Of Derivative Liability Amount Not Offset Against Collateral DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral	1210000000	usd
CY2023Q4	us-gaap	Derivative Liability Fair Value Gross Asset DerivativeLiabilityFairValueGrossAsset	0	usd
CY2023Q4	us-gaap	Derivative Liabilities DerivativeLiabilities	1210000000	usd
CY2023Q4	us-gaap	Derivative Liability Not Offset Policy Election Deduction DerivativeLiabilityNotOffsetPolicyElectionDeduction	273000000	usd
CY2023Q4	us-gaap	Derivative Collateral Right To Reclaim Cash DerivativeCollateralRightToReclaimCash	6000000	usd
CY2023Q4	us-gaap	Derivative Collateral Right To Reclaim Securities DerivativeCollateralRightToReclaimSecurities	744000000	usd
CY2023Q4	us-gaap	Derivative Fair Value Of Derivative Liability Amount Offset Against Collateral DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral	187000000	usd
CY2023Q4	us-gaap	Securities Loaned Gross SecuritiesLoanedGross	19000000	usd
CY2023Q4	us-gaap	Securities Loaned Asset SecuritiesLoanedAsset	0	usd
CY2023Q4	us-gaap	Securities Loaned SecuritiesLoaned	19000000	usd
CY2023Q4	us-gaap	Securities Loaned Not Offset Policy Election Deduction SecuritiesLoanedNotOffsetPolicyElectionDeduction	0	usd
CY2023Q4	us-gaap	Securities Loaned Collateral Right To Reclaim Cash SecuritiesLoanedCollateralRightToReclaimCash	19000000	usd
CY2023Q4	us-gaap	Securities Loaned Collateral Right To Reclaim Securities SecuritiesLoanedCollateralRightToReclaimSecurities	0	usd
CY2023Q4	us-gaap	Securities Loaned Amount Offset Against Collateral SecuritiesLoanedAmountOffsetAgainstCollateral	0	usd
CY2023Q4	us-gaap	Securities Sold Under Agreements To Repurchase Gross SecuritiesSoldUnderAgreementsToRepurchaseGross	0	usd
CY2023Q4	us-gaap	Securities Sold Under Agreements To Repurchase Asset SecuritiesSoldUnderAgreementsToRepurchaseAsset	0	usd
CY2023Q4	us-gaap	Securities Sold Under Agreements To Repurchase SecuritiesSoldUnderAgreementsToRepurchase	0	usd
CY2023Q4	us-gaap	Securities Sold Under Agreements To Resell Not Offset Policy Election Deduction SecuritiesSoldUnderAgreementsToResellNotOffsetPolicyElectionDeduction	0	usd
CY2023Q4	us-gaap	Securities Sold Under Agreements To Repurchase Collateral Right To Reclaim Cash SecuritiesSoldUnderAgreementsToRepurchaseCollateralRightToReclaimCash	0	usd
CY2023Q4	us-gaap	Securities Sold Under Agreements To Repurchase Collateral Right To Reclaim Securities SecuritiesSoldUnderAgreementsToRepurchaseCollateralRightToReclaimSecurities	0	usd
CY2023Q4	us-gaap	Securities Sold Under Agreements To Repurchase Amount Offset Against Collateral SecuritiesSoldUnderAgreementsToRepurchaseAmountOffsetAgainstCollateral	0	usd
CY2023Q4	us-gaap	Derivative Liability Securities Sold Under Agreements To Resell Securities Loaned Gross DerivativeLiabilitySecuritiesSoldUnderAgreementsToResellSecuritiesLoanedGross	1229000000	usd
CY2023Q4	us-gaap	Derivative Liability Securities Sold Under Agreements To Resell Securities Loaned Asset DerivativeLiabilitySecuritiesSoldUnderAgreementsToResellSecuritiesLoanedAsset	0	usd
CY2023Q4	us-gaap	Derivative Liability Securities Sold Under Agreements To Resell Securities Loaned DerivativeLiabilitySecuritiesSoldUnderAgreementsToResellSecuritiesLoaned	1229000000	usd
CY2023Q4	us-gaap	Derivative Liability Securities Sold Under Agreements To Resell Securities Loaned Not Offset Policy Election Deduction DerivativeLiabilitySecuritiesSoldUnderAgreementsToResellSecuritiesLoanedNotOffsetPolicyElectionDeduction	273000000	usd
CY2023Q4	us-gaap	Derivative Liability Securities Sold Under Agreements To Resell Securities Loaned Collateral Right To Reclaim Cash DerivativeLiabilitySecuritiesSoldUnderAgreementsToResellSecuritiesLoanedCollateralRightToReclaimCash	25000000	usd
CY2023Q4	us-gaap	Derivative Liability Securities Sold Under Agreements To Resell Securities Loaned Collateral Right To Reclaim Securities DerivativeLiabilitySecuritiesSoldUnderAgreementsToResellSecuritiesLoanedCollateralRightToReclaimSecurities	744000000	usd
CY2023Q4	us-gaap	Derivative Liability Securities Sold Under Agreements To Resell Securities Loaned Amount Offset Against Collateral DerivativeLiabilitySecuritiesSoldUnderAgreementsToResellSecuritiesLoanedAmountOffsetAgainstCollateral	187000000	usd
CY2024Q1	jxn	Financing Receivable Fair Value Option FinancingReceivableFairValueOption	455000000	usd
CY2023Q4	jxn	Financing Receivable Fair Value Option FinancingReceivableFairValueOption	481000000	usd
CY2024Q1	us-gaap	Equity Securities Fv Ni Current And Noncurrent EquitySecuritiesFvNiCurrentAndNoncurrent	222000000	usd
CY2024Q1	jxn	Financing Receivable Fair Value Option FinancingReceivableFairValueOption	455000000	usd
CY2024Q1	jxn	Investments In Limited Partnerships InvestmentsInLimitedPartnerships	137000000	usd
CY2024Q1	jxn	Loans Gross Insurance Policy Fair Value Option LoansGrossInsurancePolicyFairValueOption	3448000000	usd
CY2024Q1	us-gaap	Derivative Assets DerivativeAssets	213000000	usd
CY2024Q1	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	2542000000	usd
CY2024Q1	jxn	Gmib Reinsurance Recoverable GMIBReinsuranceRecoverable	126000000	usd
CY2024Q1	us-gaap	Market Risk Benefit Asset Amount MarketRiskBenefitAssetAmount	8025000000	usd
CY2024Q1	us-gaap	Separate Account Assets SeparateAccountAssets	230773000000	usd
CY2024Q1	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	288357000000	usd
CY2024Q1	us-gaap	Embedded Derivative Fair Value Of Embedded Derivative Liability EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability	2568000000	usd
CY2024Q1	jxn	Funds Withheld Payable Under Reinsurance Treaties FundsWithheldPayableUnderReinsuranceTreaties	1122000000	usd
CY2024Q1	us-gaap	Derivative Liabilities DerivativeLiabilities	1288000000	usd
CY2024Q1	us-gaap	Market Risk Benefit Liability Amount MarketRiskBenefitLiabilityAmount	3843000000	usd
CY2024Q1	us-gaap	Liabilities Fair Value Disclosure LiabilitiesFairValueDisclosure	10889000000	usd
CY2024Q1	us-gaap	Alternative Investment AlternativeInvestment	2090000000	usd
CY2023Q4	us-gaap	Equity Securities Fv Ni Current And Noncurrent EquitySecuritiesFvNiCurrentAndNoncurrent	394000000	usd
CY2023Q4	jxn	Financing Receivable Fair Value Option FinancingReceivableFairValueOption	481000000	usd
CY2023Q4	jxn	Investments In Limited Partnerships InvestmentsInLimitedPartnerships	135000000	usd
CY2023Q4	jxn	Loans Gross Insurance Policy Fair Value Option LoansGrossInsurancePolicyFairValueOption	3457000000	usd
CY2023Q4	us-gaap	Derivative Assets DerivativeAssets	390000000	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	2688000000	usd
CY2023Q4	jxn	Gmib Reinsurance Recoverable GMIBReinsuranceRecoverable	149000000	usd
CY2023Q4	us-gaap	Market Risk Benefit Asset Amount MarketRiskBenefitAssetAmount	6737000000	usd
CY2023Q4	us-gaap	Separate Account Assets SeparateAccountAssets	219656000000	usd
CY2023Q4	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	276730000000	usd
CY2023Q4	us-gaap	Embedded Derivative Fair Value Of Embedded Derivative Liability EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability	2090000000	usd
CY2023Q4	jxn	Funds Withheld Payable Under Reinsurance Treaties FundsWithheldPayableUnderReinsuranceTreaties	1158000000	usd
CY2023Q4	us-gaap	Derivative Liabilities DerivativeLiabilities	1210000000	usd
CY2023Q4	us-gaap	Market Risk Benefit Liability Amount MarketRiskBenefitLiabilityAmount	4785000000	usd
CY2023Q4	us-gaap	Liabilities Fair Value Disclosure LiabilitiesFairValueDisclosure	11231000000	usd
CY2023Q4	us-gaap	Alternative Investment AlternativeInvestment	1997000000	usd
CY2024Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Purchases FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases	138000000	usd
CY2024Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Sales FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales	140000000	usd
CY2024Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Issues FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetIssues	63000000	usd
CY2024Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Settlements FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements	101000000	usd
CY2024Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Purchases Sales Issuances Settlements FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchasesSalesIssuancesSettlements	-40000000	usd
CY2023Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Purchases FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases	55000000	usd
CY2023Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Sales FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales	148000000	usd
CY2023Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Issues FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetIssues	35000000	usd
CY2023Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Settlements FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements	56000000	usd
CY2023Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Purchases Sales Issuances Settlements FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchasesSalesIssuancesSettlements	-114000000	usd
CY2024Q1	jxn	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers In Out Of Level3 FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersInOutOfLevel3	9000000	usd
CY2024Q1	jxn	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Into Out Of Level3 FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoOutOfLevel3	15000000	usd
CY2023Q1	jxn	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers In Out Of Level3 FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersInOutOfLevel3	37000000	usd
CY2023Q1	jxn	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Into Out Of Level3 FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoOutOfLevel3	11000000	usd
CY2023Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Net FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet	7000000	usd
CY2023	jxn	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Into Out Of Level3 FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoOutOfLevel3	1336000000	usd
CY2024Q1	us-gaap	Loans Receivable Fair Value Disclosure LoansReceivableFairValueDisclosure	9899000000	usd
CY2024Q1	jxn	Loans Gross Insurance Policy Excluding At Fair Value Under Fair Value Option LoansGrossInsurancePolicyExcludingAtFairValueUnderFairValueOption	938000000	usd
CY2024Q1	us-gaap	Investment In Federal Home Loan Bank Stock Fair Value Disclosure InvestmentInFederalHomeLoanBankStockFairValueDisclosure	127000000	usd
CY2024Q1	jxn	Liability For Future Policy Benefits Annuity Reserves LiabilityForFuturePolicyBenefitsAnnuityReserves	33062000000	usd
CY2024Q1	us-gaap	Liabilities Related To Investment Contracts Fair Value Disclosure LiabilitiesRelatedToInvestmentContractsFairValueDisclosure	640000000	usd
CY2024Q1	us-gaap	Security Owned And Pledged As Collateral Associated Liabilities Fair Value SecurityOwnedAndPledgedAsCollateralAssociatedLiabilitiesFairValue	5185000000	usd
CY2024Q1	us-gaap	Federal Funds Purchased Fair Value Disclosure FederalFundsPurchasedFairValueDisclosure	2000000000	usd
CY2024Q1	jxn	Funds Held Under Reinsurance Agreements Liability Excluding At Fair Value Under Fair Value Option FundsHeldUnderReinsuranceAgreementsLiabilityExcludingAtFairValueUnderFairValueOption	18122000000	usd
CY2024Q1	us-gaap	Debt Instrument Fair Value DebtInstrumentFairValue	2033000000	usd
CY2024Q1	us-gaap	Securities Loaned SecuritiesLoaned	21000000	usd
CY2024Q1	us-gaap	Assets Sold Under Agreements To Repurchase Repurchase Liability AssetsSoldUnderAgreementsToRepurchaseRepurchaseLiability	1799000000	usd
CY2024Q1	us-gaap	Separate Accounts Liability SeparateAccountsLiability	230773000000	usd
CY2023Q4	us-gaap	Loans Receivable Fair Value Disclosure LoansReceivableFairValueDisclosure	10082000000	usd
CY2023Q4	jxn	Loans Gross Insurance Policy Excluding At Fair Value Under Fair Value Option LoansGrossInsurancePolicyExcludingAtFairValueUnderFairValueOption	942000000	usd
CY2023Q4	us-gaap	Investment In Federal Home Loan Bank Stock Fair Value Disclosure InvestmentInFederalHomeLoanBankStockFairValueDisclosure	108000000	usd
CY2023Q4	jxn	Liability For Future Policy Benefits Annuity Reserves LiabilityForFuturePolicyBenefitsAnnuityReserves	33161000000	usd
CY2023Q4	us-gaap	Liabilities Related To Investment Contracts Fair Value Disclosure LiabilitiesRelatedToInvestmentContractsFairValueDisclosure	700000000	usd
CY2023Q4	us-gaap	Security Owned And Pledged As Collateral Associated Liabilities Fair Value SecurityOwnedAndPledgedAsCollateralAssociatedLiabilitiesFairValue	5756000000	usd
CY2023Q4	us-gaap	Federal Funds Purchased Fair Value Disclosure FederalFundsPurchasedFairValueDisclosure	1950000000	usd
CY2023Q4	jxn	Funds Held Under Reinsurance Agreements Liability Excluding At Fair Value Under Fair Value Option FundsHeldUnderReinsuranceAgreementsLiabilityExcludingAtFairValueUnderFairValueOption	18794000000	usd
CY2023Q4	us-gaap	Debt Instrument Fair Value DebtInstrumentFairValue	2037000000	usd
CY2023Q4	us-gaap	Securities Loaned SecuritiesLoaned	19000000	usd
CY2023Q4	us-gaap	Federal Home Loan Bank Borrowings Fair Value Disclosure FederalHomeLoanBankBorrowingsFairValueDisclosure	250000000	usd
CY2023Q4	us-gaap	Separate Accounts Liability SeparateAccountsLiability	219656000000	usd
CY2024Q1	jxn	Federal Home Loan Bank Capital Stock Share Price FederalHomeLoanBankCapitalStockSharePrice	100
CY2024Q1	us-gaap	Deferred Policy Acquisition Costs Text Block1 DeferredPolicyAcquisitionCostsTextBlock1	Deferred Acquisition Costs<div style="padding-left:0.18pt;padding-right:-18.35pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain costs that are directly related to the successful acquisition of new or renewal insurance business are capitalized as deferred acquisition costs ("DAC") in the period in which they are incurred. These costs primarily pertain to commissions and certain costs associated with policy issuance and underwriting. All other acquisition costs are expensed as incurred.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Contracts are grouped into cohorts by contract type and issue year. For traditional and limited-payment insurance contracts, contracts are grouped consistent with the groupings used in estimating the associated liability. DAC are amortized into expense on a constant level basis over the expected term of the grouped contracts. For traditional and limited-payment insurance contracts, amortization is determined based on projected in force amounts. For non-traditional contracts, amortization is determined based on projected policy counts</span><span style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:0.18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The expected term used to amortize DAC is determined using best estimate assumptions, including mortality and persistency, consistent with the best estimate assumptions used to determine the reserve for future policy benefits, MRBs, and additional liabilities for applicable contracts. For amortization of DAC related to contracts without these balances, assumptions used to determine expected term are developed in a similar manner. The amortization rate is determined using all information available as of the end of the reporting period, including actual experience and any assumption updates. Annually, or as circumstances warrant, a comprehensive review of assumptions is conducted, and assumptions are revised as appropriate. If assumptions are revised, the amortization rate is calculated using revised assumptions such that the effect of revised assumptions is recognized prospectively as of the beginning of that reporting period. </span></div><div style="padding-left:0.18pt;text-align:justify"><span><br/></span></div><div style="padding-left:0.18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unamortized DAC are written off when a contract is internally replaced and substantially changed. Substantially unchanged contracts are treated as a continuation of the replaced contract, with no change to the unamortized DAC at the time of the replacement. </span></div><div style="padding-left:0.18pt;text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the roll-forward of the DAC (in millions). The current period amortization is based on the end of the period estimates of mortality and persistency. The amortization pattern is revised on a prospective basis at the beginning of the period based on the period’s actual experience.</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.917%"><tr><td style="width:1.0%"></td><td style="width:65.617%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.482%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.766%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.635%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Three Months Ended March 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Variable Annuities</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Balance, beginning of period</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">11,967 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">12,699 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Deferrals of acquisition costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">98 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">394 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(269)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1,126)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Variable Annuities balance, end of period</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">11,796 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">11,967 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Reconciliation of total DAC</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Variable Annuities balance, end of period</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">11,796 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">11,967 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Other product lines, end of period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">377 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">335 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Total balance, end of period</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">12,173 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">12,302 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div>
CY2024Q1	us-gaap	Value Of Business Acquired Voba ValueOfBusinessAcquiredVOBA	377000000	usd
CY2023Q4	us-gaap	Value Of Business Acquired Voba ValueOfBusinessAcquiredVOBA	335000000	usd
CY2024Q1	us-gaap	Deferred Policy Acquisition Costs And Value Of Business Acquired DeferredPolicyAcquisitionCostsAndValueOfBusinessAcquired	12173000000	usd
CY2023Q4	us-gaap	Deferred Policy Acquisition Costs And Value Of Business Acquired DeferredPolicyAcquisitionCostsAndValueOfBusinessAcquired	12302000000	usd
CY2024Q1	us-gaap	Reinsurance Recoverables Allowance ReinsuranceRecoverablesAllowance	30000000	usd
CY2023Q4	us-gaap	Reinsurance Recoverables Allowance ReinsuranceRecoverablesAllowance	29000000	usd
CY2024Q1	us-gaap	Reinsurance Receivables Case Basis ReinsuranceReceivablesCaseBasis	659000000	usd
CY2023Q4	us-gaap	Reinsurance Receivables Case Basis ReinsuranceReceivablesCaseBasis	669000000	usd
CY2024Q1	us-gaap	Reinsurance Recoverables ReinsuranceRecoverables	24558000000	usd
CY2023Q4	us-gaap	Reinsurance Recoverables ReinsuranceRecoverables	25422000000	usd
CY2024Q1	us-gaap	Market Risk Benefit Reinsurance Recoverable After Allowance MarketRiskBenefitReinsuranceRecoverableAfterAllowance	126000000	usd
CY2023Q4	us-gaap	Market Risk Benefit Reinsurance Recoverable After Allowance MarketRiskBenefitReinsuranceRecoverableAfterAllowance	149000000	usd
CY2024Q1	jxn	Funds Held Under Reinsurance Agreements Asset Liability Net FundsHeldUnderReinsuranceAgreementsAssetLiabilityNet	19524000000	usd
CY2023Q4	jxn	Funds Held Under Reinsurance Agreements Asset Liability Net FundsHeldUnderReinsuranceAgreementsAssetLiabilityNet	20226000000	usd
CY2024Q1	us-gaap	Funds Held Under Reinsurance Agreements Liability FundsHeldUnderReinsuranceAgreementsLiability	19244000000	usd
CY2023Q4	us-gaap	Funds Held Under Reinsurance Agreements Liability FundsHeldUnderReinsuranceAgreementsLiability	19952000000	usd
CY2024Q1	jxn	Liability For Future Policy Benefit Before Reinsurance Reserve LiabilityForFuturePolicyBenefitBeforeReinsuranceReserve	9027000000	usd
CY2023Q4	jxn	Liability For Future Policy Benefit Before Reinsurance Reserve LiabilityForFuturePolicyBenefitBeforeReinsuranceReserve	9299000000	usd
CY2024Q1	jxn	Liability For Future Policy Benefit Before Reinsurance Additional Liabilities For Insurance Guarantees LiabilityForFuturePolicyBenefitBeforeReinsuranceAdditionalLiabilitiesForInsuranceGuarantees	1125000000	usd
CY2023Q4	jxn	Liability For Future Policy Benefit Before Reinsurance Additional Liabilities For Insurance Guarantees LiabilityForFuturePolicyBenefitBeforeReinsuranceAdditionalLiabilitiesForInsuranceGuarantees	1153000000	usd
CY2024Q1	jxn	Liability For Future Policy Benefit Before Reinsurance Other Insurance And Annuity Liabilities LiabilityForFuturePolicyBenefitBeforeReinsuranceOtherInsuranceAndAnnuityLiabilities	1433000000	usd
CY2023Q4	jxn	Liability For Future Policy Benefit Before Reinsurance Other Insurance And Annuity Liabilities LiabilityForFuturePolicyBenefitBeforeReinsuranceOtherInsuranceAndAnnuityLiabilities	1446000000	usd
CY2024Q1	jxn	Policyholder Account Balance Liability For Future Policy Benefits And Unpaid Claims And Claims Adjustment Expense PolicyholderAccountBalanceLiabilityForFuturePolicyBenefitsAndUnpaidClaimsAndClaimsAdjustmentExpense	11585000000	usd
CY2023Q4	jxn	Policyholder Account Balance Liability For Future Policy Benefits And Unpaid Claims And Claims Adjustment Expense PolicyholderAccountBalanceLiabilityForFuturePolicyBenefitsAndUnpaidClaimsAndClaimsAdjustmentExpense	11898000000	usd
CY2024Q1	us-gaap	Liability For Future Policy Benefit Gross Premium Income LiabilityForFuturePolicyBenefitGrossPremiumIncome	89000000	usd
CY2023	us-gaap	Liability For Future Policy Benefit Gross Premium Income LiabilityForFuturePolicyBenefitGrossPremiumIncome	363000000	usd
CY2024Q1	us-gaap	Liability For Future Policy Benefit Interest Expense LiabilityForFuturePolicyBenefitInterestExpense	90000000	usd
CY2023	us-gaap	Liability For Future Policy Benefit Interest Expense LiabilityForFuturePolicyBenefitInterestExpense	394000000	usd
CY2024Q1	jxn	Funding Agreement FundingAgreement	2000000000.0	usd
CY2023Q4	jxn	Funding Agreement FundingAgreement	2300000000	usd
CY2024Q1	jxn	Borrowings On Mortgage Related Securities And Commercial Mortgage Loans BorrowingsOnMortgageRelatedSecuritiesAndCommercialMortgageLoans	3100000000	usd
CY2023	jxn	Borrowings On Mortgage Related Securities And Commercial Mortgage Loans BorrowingsOnMortgageRelatedSecuritiesAndCommercialMortgageLoans	3500000000	usd
CY2024Q1	us-gaap	Other Policyholder Funds OtherPolicyholderFunds	54897000000	usd
CY2023Q4	us-gaap	Other Policyholder Funds OtherPolicyholderFunds	55319000000	usd
CY2024Q1	us-gaap	Separate Account Assets SeparateAccountAssets	231000000000	usd
CY2023Q4	us-gaap	Separate Account Assets SeparateAccountAssets	220000000000	usd
CY2024Q1	us-gaap	Separate Account Assets SeparateAccountAssets	230773000000	usd
CY2023Q4	us-gaap	Separate Account Assets SeparateAccountAssets	219656000000	usd
CY2024Q1	us-gaap	Separate Account Assets SeparateAccountAssets	230773000000	usd
CY2023Q4	us-gaap	Separate Account Assets SeparateAccountAssets	219656000000	usd
CY2024Q1	us-gaap	Market Risk Benefit Asset Amount MarketRiskBenefitAssetAmount	8025000000	usd
CY2023Q4	us-gaap	Market Risk Benefit Asset Amount MarketRiskBenefitAssetAmount	6737000000	usd
CY2024Q1	us-gaap	Market Risk Benefit Liability Amount MarketRiskBenefitLiabilityAmount	3843000000	usd
CY2023Q4	us-gaap	Market Risk Benefit Liability Amount MarketRiskBenefitLiabilityAmount	4785000000	usd
CY2024Q1	us-gaap	Market Risk Benefit After Increase Decrease From Instrument Specific Credit Risk MarketRiskBenefitAfterIncreaseDecreaseFromInstrumentSpecificCreditRisk	-4182000000	usd
CY2023Q4	us-gaap	Market Risk Benefit After Increase Decrease From Instrument Specific Credit Risk MarketRiskBenefitAfterIncreaseDecreaseFromInstrumentSpecificCreditRisk	-1952000000	usd
CY2024Q1	us-gaap	Long Term Debt LongTermDebt	2033000000	usd
CY2023Q4	us-gaap	Long Term Debt LongTermDebt	2037000000	usd
CY2024Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	0	usd
CY2024Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	0	usd
CY2024Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	648000000	usd
CY2024Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	0	usd
CY2024Q1	jxn	Long Term Debt Maturity Year Five And Thereafter LongTermDebtMaturityYearFiveAndThereafter	1385000000	usd
CY2024Q1	us-gaap	Long Term Debt LongTermDebt	2033000000	usd
CY2024Q1	us-gaap	Federal Home Loan Bank Advances Branch Of Fhlb Bank Amount Of Advances By Branch FederalHomeLoanBankAdvancesBranchOfFHLBBankAmountOfAdvancesByBranch	0	usd
CY2023Q4	us-gaap	Federal Home Loan Bank Advances Branch Of Fhlb Bank Amount Of Advances By Branch FederalHomeLoanBankAdvancesBranchOfFHLBBankAmountOfAdvancesByBranch	250000000	usd
CY2024Q1	us-gaap	Interest Expense Federal Home Loan Bank And Federal Reserve Bank Advances Short Term InterestExpenseFederalHomeLoanBankAndFederalReserveBankAdvancesShortTerm	0	usd
CY2023Q1	us-gaap	Interest Expense Federal Home Loan Bank And Federal Reserve Bank Advances Short Term InterestExpenseFederalHomeLoanBankAndFederalReserveBankAdvancesShortTerm	0	usd
CY2024Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.113
CY2023Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.272
CY2023	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.005
CY2024Q1	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals	111000000	usd
CY2023Q1	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals	0	usd
CY2024Q1	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	1000000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	1000000	usd
CY2024Q1	jxn	Asset Based Commission Expense AssetBasedCommissionExpense	279000000	usd
CY2023Q1	jxn	Asset Based Commission Expense AssetBasedCommissionExpense	250000000	usd
CY2024Q1	jxn	Other Commission Expense OtherCommissionExpense	203000000	usd
CY2023Q1	jxn	Other Commission Expense OtherCommissionExpense	174000000	usd
CY2024Q1	jxn	Sub Advisor Expenses SubAdvisorExpenses	80000000	usd
CY2023Q1	jxn	Sub Advisor Expenses SubAdvisorExpenses	77000000	usd
CY2024Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	271000000	usd
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	236000000	usd
CY2024Q1	jxn	Deferral Of Acquisition Costs And Sales Inducement Assets DeferralOfAcquisitionCostsAndSalesInducementAssets	148000000	usd
CY2023Q1	jxn	Deferral Of Acquisition Costs And Sales Inducement Assets DeferralOfAcquisitionCostsAndSalesInducementAssets	121000000	usd
CY2024Q1	us-gaap	Costs And Expenses CostsAndExpenses	685000000	usd
CY2023Q1	us-gaap	Costs And Expenses CostsAndExpenses	616000000	usd
CY2024Q1	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Reclassification Adjustments Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax	-282000000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Reclassification Adjustments Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax	1027000000	usd
CY2024Q1	us-gaap	Oci Liability For Future Policy Benefit Gain Loss After Reclassification Adjustment Before Tax OciLiabilityForFuturePolicyBenefitGainLossAfterReclassificationAdjustmentBeforeTax	81000000	usd
CY2023Q1	us-gaap	Oci Liability For Future Policy Benefit Gain Loss After Reclassification Adjustment Before Tax OciLiabilityForFuturePolicyBenefitGainLossAfterReclassificationAdjustmentBeforeTax	-146000000	usd
CY2024Q1	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax	511000000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax	-284000000	usd
CY2024Q1	jxn	Oci Other Unrealized Gain Loss Before Reclassifications Net Of Tax OCIOtherUnrealizedGainLossBeforeReclassificationsNetOfTax	4000000	usd
CY2023Q1	jxn	Oci Other Unrealized Gain Loss Before Reclassifications Net Of Tax OCIOtherUnrealizedGainLossBeforeReclassificationsNetOfTax	-14000000	usd
CY2024Q1	jxn	Oci Increase Decrease In Deferred Tax Asset Before Reclassifications Net Of Tax OCIIncreaseDecreaseInDeferredTaxAssetBeforeReclassificationsNetOfTax	95000000	usd
CY2023Q1	jxn	Oci Increase Decrease In Deferred Tax Asset Before Reclassifications Net Of Tax OCIIncreaseDecreaseInDeferredTaxAssetBeforeReclassificationsNetOfTax	-110000000	usd
CY2024Q1	us-gaap	Other Comprehensive Income Loss Before Reclassifications Net Of Tax OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax	-613000000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Before Reclassifications Net Of Tax OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax	1041000000	usd
CY2024Q1	us-gaap	Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax	2000000	usd
CY2023Q1	us-gaap	Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax	-29000000	usd
CY2024Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-615000000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	1070000000	usd
CY2024Q1	us-gaap	Preferred Stock Dividends Per Share Cash Paid PreferredStockDividendsPerShareCashPaid	500
CY2024Q1	jxn	Number Of Classes Of Common Stock NumberOfClassesOfCommonStock	2	class
CY2023Q1	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	450000000	usd
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	78660221	shares
CY2024Q1	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	118525	shares
CY2024Q1	us-gaap	Stock Issued During Period Shares Share Based Compensation StockIssuedDuringPeriodSharesShareBasedCompensation	-2157372	shares
CY2024Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	76621374	shares
CY2024Q1	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.70
CY2023Q1	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.62
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	795000000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-1497000000	usd
CY2024Q1	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	11000000	usd
CY2023Q1	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	0	usd
CY2024Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	784000000	usd
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-1497000000	usd
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	78059817	shares
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	82646113	shares
CY2024Q1	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	807286	shares
CY2023Q1	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0	shares
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	78867103	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	82646113	shares
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	10.04
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-18.11
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	9.94
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-18.11
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	3436857	shares
CY2024Q1	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q1	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2024Q1	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false

Files In Submission

Name	View Source	Status
0001822993-24-000020-index-headers.html	Edgar Link	pending
0001822993-24-000020-index.html	Edgar Link	pending
0001822993-24-000020.txt	Edgar Link	pending
0001822993-24-000020-xbrl.zip	Edgar Link	pending
exhibit101formofnoticeofan.htm	Edgar Link	pending
exhibit102formofnoticeofaw.htm	Edgar Link	pending
exhibit103noticeofawardofr.htm	Edgar Link	pending
exhibit311_q1-2024.htm	Edgar Link	pending
exhibit312_q1-2024.htm	Edgar Link	pending
exhibit321_q1-2024.htm	Edgar Link	pending
exhibit322_q1-2024.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
jxn-20240331.htm	Edgar Link	pending
jxn-20240331.xsd	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R100.htm	Edgar Link	pending
R101.htm	Edgar Link	pending
R102.htm	Edgar Link	pending
R103.htm	Edgar Link	pending
R104.htm	Edgar Link	pending
R105.htm	Edgar Link	pending
R106.htm	Edgar Link	pending
R107.htm	Edgar Link	pending
R108.htm	Edgar Link	pending
R109.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R110.htm	Edgar Link	pending
R111.htm	Edgar Link	pending
R112.htm	Edgar Link	pending
R113.htm	Edgar Link	pending
R114.htm	Edgar Link	pending
R115.htm	Edgar Link	pending
R116.htm	Edgar Link	pending
R117.htm	Edgar Link	pending
R118.htm	Edgar Link	pending
jxn-20240331_cal.xml	Edgar Link	unprocessable
jxn-20240331_def.xml	Edgar Link	unprocessable
jxn-20240331_pre.xml	Edgar Link	unprocessable
jxn-20240331_htm.xml	Edgar Link	completed
R119.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R120.htm	Edgar Link	pending
R121.htm	Edgar Link	pending
R122.htm	Edgar Link	pending
R123.htm	Edgar Link	pending
R124.htm	Edgar Link	pending
R125.htm	Edgar Link	pending
R126.htm	Edgar Link	pending
R127.htm	Edgar Link	pending
R128.htm	Edgar Link	pending
R129.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
R91.htm	Edgar Link	pending
R92.htm	Edgar Link	pending
R93.htm	Edgar Link	pending
R94.htm	Edgar Link	pending
R95.htm	Edgar Link	pending
R96.htm	Edgar Link	pending
R97.htm	Edgar Link	pending
R98.htm	Edgar Link	pending
R99.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
jxn-20240331_lab.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$JXN
Jackson Financial Inc. Stock $jxn

2024 Q2 Form 10-Q Financial Statement

#000182299324000020 Filed on May 08, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$JXN Jackson Financial Inc. Stock $jxn

2024 Q2 Form 10-Q Financial Statement

#000182299324000020 Filed on May 08, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$JXN
Jackson Financial Inc. Stock $jxn